carbapenems has been researched along with colistin in 477 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (colistin) | Trials (colistin) | Recent Studies (post-2010) (colistin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 5,449 | 198 | 3,262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.21) | 18.2507 |
| 2000's | 21 (4.40) | 29.6817 |
| 2010's | 267 (55.97) | 24.3611 |
| 2020's | 188 (39.41) | 2.80 |
| Authors | Studies |
|---|---|
| Corbella, X; Corral, L; Fernandez-Viladrich, P; Mateu, A; Tubau, F | 1 |
| Henwood, CJ; James, D; Livermore, DM; Spence, RP; Towner, KJ; Woodford, N | 1 |
| Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F | 1 |
| Cecchini, L; Chinello, P; Esposito, S; Franchi, C; Masala, M; Nicastri, E; Petrosillo, N; Proietti, MF; Venditti, M | 1 |
| Chang, SC; Huang, YT; Lauderdale, TL; Wang, JT; Yang, AJ | 1 |
| Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
| Cheong, HJ; Hwang, IS; Jeong, HW; Kee, SY; Kim, WJ; Seo, YB; Song, JY | 1 |
| Giamarellos-Bourboulis, E; Koutsoukou, A; Kraniotaki, H; Mentzelopoulos, SD; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Zakynthinos, SG; Zervakis, D | 1 |
| Barone, AA; Costa, SF; De Pedri, EH; Duboc, G; Fung, L; Levin, AS; Rossi, F; van der Heijden, IM | 1 |
| Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
| Ahn, BJ; Jin, JS; Kim, JU; Lee, JC; Lee, SH; Lee, WK; Lee, YC; Song, DY | 1 |
| Durante-Mangoni, E; Fortunato, R; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Falagas, ME; Koletsi, PK; Kopterides, P; Michalopoulos, A | 1 |
| Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A | 1 |
| Giamarellou, H; Kanellakopoulou, K | 1 |
| Choi, CH; Heo, ST; Jeong, YG; Jin, JS; Kim, JW; Kim, SJ; Lee, JC; Lee, YC | 1 |
| Cheong, HJ; Heo, JY; Hwang, IS; Kim, WJ; Lee, J; Noh, JY; Song, JY | 1 |
| Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK | 1 |
| Martínez-Martínez, L | 1 |
| Adler, A; Benenson, S; Block, C; Carmeli, Y; Moses, AE; Navon-Venezia, S; Strahilevitz, J | 1 |
| Chen, CC; Chen, CH; Chiang, SR; Chou, CH; Chuang, YC; Ko, WC; Lee, NY; Tang, HJ | 1 |
| Ergin, A; Eser, OK; Hasçelik, G | 1 |
| Amornnopparattanakul, S; Dhiraputra, C; Fungwithaya, S; Leelarasamee, A; Nannha, P; Panapakdee, S; Pongpech, P | 1 |
| Böröcz, K; Damjanova, I; Dobák, A; Farkas, M; Jánvári, L; Pászti, J; Puskás, E; Tóth, A | 1 |
| Otük, G; Ozbek, B | 1 |
| Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
| Antoniadou, E; Kontopoulou, K; Koteli, A; Kriti, M; Protonotariou, E; Sofianou, D; Vasilakos, K | 1 |
| De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M | 1 |
| Baritaki, S; Georgiladakis, A; Maraki, S; Messaritakis, H; Neonakis, IK; Samonis, G; Spandidos, DA | 1 |
| Bheemreddy, S; Blunden, C; Bonomo, RA; Chen, TY; Chopra, T; Dhar, S; Endimiani, A; Hafeez, W; Hothi, J; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Moshos, J; Navon-Venezia, S; Perez, F; Pogue, JM; Reid, D; Rudin, S; Salimnia, H; Shango, M; Slim, J | 1 |
| Adams-Haduch, JM; Clancy, CJ; Crespo, M; Doi, Y; Kwak, EJ; Nguyen, MH; Pasculle, AW; Pilewski, JM; Potoski, BA; Shields, RK; Silviera, FP; Toyoda, Y | 1 |
| Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
| Gray, JW; Patel, M | 1 |
| Bogaerts, P; Bouchahrouf, W; de Castro, RR; Denis, O; Deplano, A; Glupczynski, Y; Tsobo, C | 1 |
| Ahmad, F; Bheemreddy, S; Blunden, C; Bonomo, RA; Campbell, M; Chen, TY; Chopra, T; Dhar, S; Hayakawa, K; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Patel, D; Perez, F; Pogue, JM; Rudin, S; Salimnia, H; Shango, M; Slim, J; Varkey, J | 1 |
| Bergen, PJ; Bulitta, JB; Forrest, A; Jacob, J; Li, J; Nation, RL; Paterson, DL; Sidjabat, HE; Tsuji, BT | 1 |
| Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ | 1 |
| Kempf, M; Rolain, JM | 1 |
| Farbman, L; Leibovici, L; Paul, M; Yahav, D | 1 |
| Borer, A; Codish, S; Eskira, S; Peled, N; Polachek, H; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolykov, R; Trabelsi, Y; Yousef, B | 1 |
| Apisarnthanarak, A; Mundy, LM | 1 |
| Chayakul, P; Garey, KW; Pattharachayakul, S; Santimaleeworagun, W; Tansakul, P; Wongpoowarak, P | 1 |
| Al Najjar, M; Hamzeh, AR; Mahfoud, M | 1 |
| Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O | 1 |
| Bille, E; Carbonnelle, E; Cattoir, V; Corvec, S; Fihman, V; Illiaquer, M; Jacquier, H; Jauréguy, F; Le Monnier, A; Tankovic, J; Zahar, JR | 1 |
| Clancy, CJ; Jernigan, MG; Nguyen, MH; Press, EG; Shields, RK | 1 |
| Abreu-Lanfranco, O; Bhargava, A; Bheemreddy, S; Campbell, M; Chopra, T; Dhar, S; Hayakawa, K; Kaye, KS; Khandker, N; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Wang, Y | 1 |
| Aramă, V; Breuil, J; Hristea, A; Olaru, ID; Popoiu, M | 1 |
| Bergen, PJ; Bulitta, JB; Davis, K; Deris, ZZ; Forrest, A; Jacob, J; Ku, CK; Li, J; Nation, RL; Paterson, DL; Poudyal, A; Soon, RL; Tsuji, BT; Velkov, T; Yu, HH | 1 |
| Absar, MM; Al Aska, AI; Arshad, MZ; Fatani, AJ; Murray, TS; Shakoor, ZA; Siddiqui, YM; Somily, AM | 1 |
| Amyes, SG; Evans, BA; Hamouda, A | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Mammina, C; Palma, DM; Saporito, MA; Sodano, C; Tetamo, R; Verde, MS | 1 |
| Henderson, DK; Palmore, TN; Segre, JA; Snitkin, ES; Stock, F; Thomas, PJ; Zelazny, AM | 1 |
| Akduman, D; Aydemir, H; Celebi, G; Comert, F; Horuz, E; Kokturk, F; Ornek, T; Piskin, N; Terzi, A | 1 |
| Casini, B; Costanzo, S; Leonetti, P; Leonildi, A; Malacarne, P; Menichetti, F; Sbrana, F; Tascini, C; Viaggi, B | 1 |
| Assous, MV; Bdolah-Abram, T; Kopuit, P; Lachish, T; Shilo, S; Wiener-Well, Y; Yinnon, AM | 1 |
| Coelho-Souza, T; Dias, RC; Martins, IS; Martins, N; Menezes, AO; Moreira, BM; Reis, JN; Reis, MG; Riley, LW; Silva, NO | 1 |
| Giannella, M; Lewis, R; Petrosillo, N; Viale, P | 1 |
| Ambe, LA; Casella, LG; Doi, Y; Ernst, RK; O'Hara, JA; Pelletier, MR; Shanks, RM; Townsend, BM | 1 |
| Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Hong, JH; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK; Zhao, Y | 1 |
| Perez, F; Van Duin, D | 1 |
| Barber, KE; Kaye, KS; Mann, T; Pogue, JM | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L | 1 |
| Bonnin, RA; Nordmann, P; Poirel, L | 1 |
| Erdogan-Yildirim, Z; Manafi, M; Sauermann, R; Schwameis, R; Strommer, S; Zeitlinger, MA | 1 |
| Chen, L; Cheng, S; Clancy, CJ; Doi, Y; Farrell, AN; Hao, B; Hong, JH; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK; Zhao, Y | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 2 |
| Falagas, ME; Lourida, P; Poulikakos, P; Rafailidis, PI; Tansarli, GS | 1 |
| Alvarez-Tejado, M; Codoñer, FM; De la Cruz, F; Galván, B; Garcillán-Barcia, MP; Gómez-Gil, R; López-Camacho, E; Lorenzo, M; Manrique, M; Mingorance, J; Moatassim, Y; Pareja, E; Salanueva, IJ; Salvarelli, E; Tobes, R | 1 |
| Casari, E; Ferrario, A; Morelli, P; Piazza, A; Tordato, F | 1 |
| Aşık, G; Atasoy, AR; Ayyildiz, A; Berktaş, M; Ciftci, IH; Gül, M; Gültepe, B; Karakeçe, E; Koçoğlu, E; Köksal Çakırlar, F; Kurtoğlu, MG; Oksüz, L; Ozdemir, M; Sesli Çetin, E; Seyrek, A; Yağcı, S | 1 |
| Deb, M; Gaind, R; Maurya, V; Mohanty, S | 1 |
| Clancy, CJ; Doi, Y; Nguyen, MH; O'Hara, JA; Oleksiuk, LM; Press, EG; Shields, RK; Updike, CL | 1 |
| Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
| Barba, MJ; Bou, G; Merino, M; Poza, M; Roca, I; Sousa, MD; Vila, J | 1 |
| Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
| Karvouniaris, M; Makris, D; Manoulakas, E; Mantzarlis, K; Zakynthinos, E | 1 |
| Agalar, C; Akalin, S; Alici, O; Alp, E; Altay, FA; Altin, N; Arslan, F; Aslan, T; Balkan, II; Batirel, A; Bekiroglu, N; Celik, AD; Cesur, S; Dogan, M; Durdu, B; Duygu, F; Engin, A; Engin, DO; Gonen, I; Guclu, E; Guven, T; Hatipoglu, CA; Hosoglu, S; Karabay, O; Karahocagil, MK; Kilic, AU; Ormen, B; Ozdemir, D; Ozer, S; Oztoprak, N; Sezak, N; Turhan, V; Turker, N; Yilmaz, H | 1 |
| Chen, L; Clancy, CJ; Hao, B; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK | 1 |
| Apisarnthanarak, A; Khawcharoenporn, T; Mundy, LM; Pruetpongpun, N; Rutchanawech, S; Tiamsak, P | 1 |
| Agodi, A; Barchitta, M; Bellocchi, P; Castiglione, G; Giaquinta, L; Poulou, A; Quattrocchi, A; Romeo, MA; Santangelo, C; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Betts, JW; Hornsey, M; Phee, LM; Wareham, DW; Woodford, N | 1 |
| Andrasevic, AT; Butic, I; Goic-Barisic, I; Jelic, M; Novak, A; Radic, M; Rubic, Z; Tonkic, M | 1 |
| Ariza, J; Bergen, PJ; Li, J; Lora-Tamayo, J; Luo, X; Murillo, O; Nation, RL; Poudyal, A; Yu, HY | 1 |
| Sirijatuphat, R; Thamlikitkul, V | 1 |
| Antachopoulos, C; Dimou, V; Drossou-Agakidou, V; Iosifidis, Ε; Karampatakis, T; Katragkou, A; Orfanou, A; Roilides, E; Sarafidis, K; Tsakris, A; Tsiatsiou, O | 1 |
| Aras, S; Aydın, S; Aygün, G; Balkan, II; Kara, Z; Kuşkucu, M; Mete, B; Midilli, K; Mutcalı, SI; Özaras, R; Öztürk, R; Saltoğlu, N; Şemen, V; Tabak, F; Yemişen, M | 1 |
| Caio, C; Cormaci, R; Denaro, C; Gennaro, M; Gona, F; Mezzatesta, ML; Quattrone, C; Salerno, I; Stefani, S; Zingali, T | 1 |
| de Leeuw, EP | 1 |
| Costa, SF; Dos Santos, LC; Fu, L; Guimaraes, T; Leite, G; Levin, AS; Ramos, J; Rizek, C; Rossi, F | 1 |
| Bou, G; Cano, ME; Fernández-Cuenca, F; Garnacho-Montero, J; Gato, E; Martínez-Martínez, L; Miguel Cisneros, J; Pascual, A; Rodríguez-Baño, J; Ruíz de Alegría, C; Tomás, M; Vila, J; Villar, M | 1 |
| Bonne, SL; Christopher, KB; Danner, RL; Hohmann, SF; Hooper, DC; Kadri, SS; Moffa, MA; Orav, EJ; Palmore, T; Strich, JR; Timpone, JG; Varughese, C | 1 |
| Falagas, ME; Rafailidis, PI | 1 |
| Gonzalez-Padilla, M; López-Cerero, L; Natera, C; Pascual, A; Pontes-Moreno, A; Rivera-Espinar, F; Rivero, A; Rodríguez, M; Rodríguez-Baño, J; Rodríguez-López, F; Salcedo, I; Torre-Cisneros, J | 1 |
| Arena, F; Garcia-Fernandez, A; Giani, T; Grundmann, H; Monaco, M; Pantosti, A; Pollini, S; Raffone, M; Rossolini, GM | 1 |
| Bulitta, JB; Cheah, SE; Li, J; Nation, RL | 1 |
| Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M | 1 |
| Chen, L; Clancy, CJ; Clarke, LG; Eschenauer, GA; Kreiswirth, BN; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK | 1 |
| Alp, E; Cevahir, F; Kaynar, L; Metan, G; Pala, Ç | 1 |
| Chen, TL; Chow, SF; Liu, CP; Shih, SC; Sun, FJ; Wang, NY; Wu, AY; Yan, TR | 1 |
| Adler, B; Aranda, J; Boyce, JD; Crane, B; Deveson Lucas, D; Harper, M; Harrison, P; Henry, R; Li, J; Li, Z; Nation, RL; Powell, D | 1 |
| Ciardi, MR; Cipolla, A; D'Abramo, A; De Rosa, A; Mascellino, MT; Mastroianni, CM; Oliva, A; Savinelli, S; Vullo, V | 1 |
| Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
| Cohen, DA; Marchaim, D; Pogue, JM | 1 |
| Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
| Bassetti, M; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G | 1 |
| Bergen, PJ; Bulitta, JB; Forrest, A; Holden, PN; Landersdorfer, CB; Li, J; Ly, NS; Nation, RL; Rao, GG; Tsuji, BT | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Hsueh, PR; Hung, CC; Liao, CH; Shen, NJ; Sheng, WH; Sun, HY; Wang, JT; Yang, CJ; Yang, JL | 1 |
| Cai, Y; Di, X; Liang, B; Liu, B; Liu, Y; Ni, W; Wang, J; Wang, R; Zhang, X | 1 |
| Amaya-Villar, R; Díaz-Martín, A; Ferrándiz-Millón, C; Garnacho-Montero, J; Gutiérrez-Pizarraya, A; López-Sánchez, JM | 1 |
| Bonomo, RA; Spellberg, B | 1 |
| Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR | 1 |
| Dafopoulou, K; Dimitroulia, E; Gennimata, V; Hadjichristodoulou, C; Pournaras, S; Tsakris, A; Zarkotou, O | 1 |
| Chaiwarith, R; Inchai, J; Khositsakulchai, W; Liwsrisakun, C; Pothirat, C; Theerakittikul, T | 1 |
| Hawari, FI; Le, J; Nazer, LH; Rihani, S | 1 |
| Chuang, YC; Ku, YH; Lee, MF; Tang, HJ; Yu, WL | 1 |
| Colombo, A; Cornetta, M; Costa, E; Di Girolamo, L; Gaia, P; Lombardi, F; Moroni, A; Ramundo, F; Tejada, MR; Valaperta, R; Valisi, M | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Giammanco, A; Giuffrè, M; Mammina, C; Palma, DM; Stampone, T | 1 |
| Kaye, KS; Ortwine, JK; Pogue, JM; Sutton, JD | 1 |
| Artichowicz, W; Fudala-Ksiazek, S; Kotlarska, E; Luczkiewicz, A; Tarasewicz, K | 1 |
| Baker, S; Campbell, JI; Hien, TT; Hoang Nhu, TD; Huong Lan, NP; Le Minh, V; Minh Yen, L; Parry, CM; Thanh Tam, PT; Thi Khanh Nhu, N; Thi Loan, H; Thieu Nga, TV; Thompson, C; Thwaites, G; Thwaites, L; Trung Nghia, HD; Tuyen, HT; Van Hao, N; Van Vinh Chau, N; Vinh Phat, V | 1 |
| Cakirlar, FK; Ciftci, IH; Gonullu, N | 1 |
| Jaworowska, J; Jurczak, A; Majewski, P; Ojdana, D; Olszańska, D; Sacha, P; Sieńko, A; Tryniszewska, E; Wieczorek, P | 1 |
| Bassetti, M; Poulakou, G; Tsiodras, S | 1 |
| Abbo, LM; Aragon, L; Beduschi, T; Camargo, JF; Cantón, R; Morris, MI; Pérez-Cardona, A; Prado, CE; Simkins, J; Tekin, A | 1 |
| Aydin, M; Ceylan, MR; Cikman, A; Gulhan, B; Karagoz, A; Karakecili, F; Parlak, M | 1 |
| Barbara, CS; Caresta, E; Ceccarelli, G; D'Abramo, A; d'Ettorre, G; Mascellino, MT; Moretti, C; Oliva, A; Papoff, P; Venditti, M; Visca, P; Vullo, V | 1 |
| Antonelli, M; De Pascale, G | 1 |
| Corona, A | 1 |
| Butić, I; Cornaglia, G; Crnek, SŠ; Gužvinec, M; Kocsis, E; Krešić, S; Mazzariol, A; Tambić, A | 1 |
| Bass, SN; Bauer, SR; Gibson, GA; Lam, SW; Neuner, EA | 1 |
| Feng, Y; Huang, L; Wang, X; Xie, L; Xie, Y; Zong, Z | 1 |
| Arora, R; Chakotiya, AS; Chawla, R; Goel, R; Narula, A; Sharma, RK; Tanwar, A; Thakur, P | 1 |
| Dalekos, GN; Georgiadou, S; Mantzarlis, K; Oikonomou, O; Papagiannitsis, CC; Petinaki, E; Sarrou, S; Zakynthinos, E | 1 |
| Choi, IS; Choi, JA; Jang, SJ; Jeong, SH; Kang, SH; Kim, CM; Moon, DS; Park, G; Park, GC | 1 |
| Shah, PG; Shah, SR | 1 |
| Church, DL; Conly, J; Mataseje, LF; Mulvey, M; Peirano, G; Pitout, JD | 1 |
| Cunningham, SA; Freese, JM; Jeraldo, PR; Norgan, AP; Patel, R; Tuin, PM | 1 |
| Kumar, M | 1 |
| Chang, FY; Chen, TL; Chiu, CH; Chuang, MF; Kuo, SC; Lee, YT; Lin, JC; Wang, YC; Yang, YS | 1 |
| Bao, C; Chavda, KD; Chen, C; Chen, L; Du, H; Huang, B; Jia, W; Kreiswirth, BN; Li, A; Miao, M; Qu, F; Shan, B; Tang, YW; Xu, Y; Yu, H; Zhang, X | 1 |
| Famiglietti, A; Nastro, M; Rodriguez, CH; Vay, C | 1 |
| Arena, F; Cannatelli, A; Di Pilato, V; Fortunato, S; Giani, T; Henrici De Angelis, L; Menichetti, F; Rossolini, GM; Tascini, C | 1 |
| Anandan, S; Balaji, V; Bhuvaneshwari, T; Devi, BY; Elakkiya, M; Laishram, S; Peter, JV; Priyanka, B; Subramani, K | 1 |
| Kumar, M; Saha, S; Subudhi, E | 2 |
| Hong, DJ; Jeong, SH; Kim, JO; Lee, H; Lee, K; Yong, D; Yoon, EJ | 1 |
| Altunçekiç Yıldırım, A; Çalgın, MK; Çetinkol, Y; Telli, M | 1 |
| Chew, KL; Lin, RT; Teo, JW | 1 |
| Kraniotaki, E; Nepka, M; Perivolioti, E; Politi, L; Pournaras, S; Tsakris, A | 1 |
| Hu, YF; Liu, CP; Shih, SC; Wang, NY | 1 |
| Chavda, KD; Chen, L; Dever, LL; Kreiswirth, BN; Mathema, B; Mediavilla, JR; Patrawalla, A; Vinnard, C | 1 |
| Akova, M; Metan, G | 1 |
| Gupta, M; Singh, SK | 1 |
| Adibhesami, H; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghourchian, S; Jasemi, S; Mohammadzadeh, M; Rahbar, M; Zeraati, H | 1 |
| Bian, X; Chen, Y; Li, Y; Liu, X; Shi, J; Zhang, J; Zhao, M | 1 |
| Katsiari, M; Likousi, S; Mavroidi, A; Nikolaou, C; Palla, E; Platsouka, ED; Roussou, Z | 1 |
| Capoccia, L; Mansour, W; Menna, D; Montelione, N; Sirignano, P; Speziale, F | 1 |
| Aloj, F; Castaldi, D; D'Abramo, A; De Angelis, M; Gizzi, F; Mascellino, MT; Mastroianni, CM; Oliva, A; Scorzolini, L; Storto, M; Vullo, V | 1 |
| Altunin, S; Benattar, YD; Daitch, V; Elbaz, M; Granot, M; Leibovici, L; Omar, M; Paul, M; Yahav, D; Zak-Doron, Y; Zusman, O | 1 |
| Camargo, CH; Costa, SF; de Maio Carrilho, CM; de Oliveira, LM; Gaudereto, J; Grion, CM; Levin, AS; Perozin, JS; Urbano, MR | 1 |
| Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM | 1 |
| Eser, OK; Ilbay, A; Metan, G; Unal, S; Zarakolu, P | 1 |
| Bonomo, RA; Cober, E; Doi, Y; Domitrovic, TN; Evans, S; Fowler, VG; Hujer, AM; Hujer, KM; Kalayjian, RC; Kaye, KS; Marshall, S; Perez, F; Richter, SS; Rojas, LJ; Rudin, SD; Salata, RA; Salim, M; van Duin, D; Watkins, RR | 1 |
| Álvarez-Marín, R; Aznar, J; Cisneros, JM; Garnacho-Montero, J; Gómez, MJ; López-Rojas, R; Márquez, JA; Molina, J; Ortiz-Leyba, C; Pachón, J | 1 |
| Cheng, GY; Guan, R; Jiang, W; Kong, LH; Lei, CW; Liu, BH; Ma, SZ; Men, S; Wang, HN; Wang, YX; Yuan, QW; Zhou, WC | 1 |
| Ardebili, A; Mardaneh, J; Razavi Nikoo, H | 1 |
| Bunk, B; Chakraborty, T; Doijad, S; Falgenhauer, L; Ghosh, H; Hilker, R; Imirzalioglu, C; Kaase, M; Overmann, J; Spröer, C; Yao, Y | 1 |
| Falgenhauer, L; Fuchs, K; Gerlach, RG; Gessner, A; Hiergeist, A; Jantsch, J; Melzl, H; Pfeifer, Y; Reischl, U; Richert, K; Simon, M | 1 |
| Doi, Y; Fang, Y; Huang, X; Lei, L; Li, HY; Liu, JH; Ren, H; Shen, J; Shen, Y; Shen, Z; Tian, GB; Tyrrell, JM; Walsh, TR; Wang, S; Wang, Y; Wu, C; Zeng, KJ; Zhang, R; Zhong, LL; Zhou, H | 1 |
| Al-Abri, SS; Al-Jardani, A; Aldeesi, Z; Carattoli, A; Darwish, D; Ghazawi, A; Hashmey, R; Jamal, W; Pál, T; Rotimi, V; Sonnevend, Á; Villa, L | 1 |
| An, JH; Jang, HC; Jeong, JH; Jung, SI; Kang, SJ; Kim, SH; Kim, YH; Moon, JE; Park, KH | 1 |
| Bustamante, P; Iredell, JR | 1 |
| Bulitta, JB; Forrest, A; Garonzik, SM; Kaye, KS; Lenhard, JR; Li, J; Nation, RL; Silveira, FP; Soo Shin, B; Tao, X; Thamlikitkul, V; Tsuji, BT | 1 |
| Mc Gann, P | 1 |
| Cancelli, F; Castaldi, D; Ciardi, MR; Cipolla, A; D'Abramo, A; D'Agostino, C; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Scorzolini, L; Vullo, V | 1 |
| Falagas, ME; Legakis, NJ; Skalidis, T; Vardakas, KZ | 1 |
| Alfaresi, M; Ghazawi, A; Girgis, S; Haidermota, A; Hashmey, R; Omar, M; Pál, T; Paterson, DL; Sonnevend, Á; Zowawi, HM | 1 |
| Acikgoz, O; Aktas, E; Cizmeci, Z; Ordekci, S; Otlu, B | 1 |
| Chen, L; Cienfuegos-Gallet, AV; Jiménez, JN; Kreiswirth, BN | 1 |
| Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
| Azar, E; Dahdouh, EA; Daoud, Z; Sarkis, DK; Soudeiha, MAH | 1 |
| Dafopoulou, K; Pournaras, S; Tsakris, A; Vourli, S; Vrioni, G | 1 |
| Antachopoulos, C; Iosifidis, E | 1 |
| Horvath, A; Ostorhazi, E; Otvos, L; Szabo, D | 1 |
| Bauerfeind, R; Ewers, C; Prenger-Berninghoff, E; Pulss, S; Semmler, T | 1 |
| Cha, MK; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, JY; Lee, JH; Lee, NY; Park, GE; Peck, KR; Seok, H; Song, JH | 1 |
| Ding, Y; Feng, Y; Hassan, B; Li, J; Li, XP; Lin, J; Sun, J; Wang, Q | 1 |
| Chang, HT; Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Sheng, WH; Sun, HY; Yang, CJ; Yang, JL | 1 |
| Hou, CJ; Hu, YF; Kuo, CF; Leung, CH; Liu, CP; Wang, NY; Wu, AY; Yeh, HI | 1 |
| Gandra, S; Gupta, P; Kaur, A; Laxminarayan, R; Mehta, Y; Sengupta, S | 1 |
| Ambretti, S; Bartoletti, M; Bartoloni, A; Bassetti, M; Cauda, R; Corcione, S; De Rosa, FG; Del Bono, V; Giacobbe, DR; Giannella, M; Lewis, RE; Losito, AR; Marchese, A; Raffaelli, F; Rossolini, GM; Saffioti, C; Spanu, T; Tedeschi, S; Trecarichi, EM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
| D'Arezzo, S; Di Caro, A; Nisii, C; Venditti, C; Vulcano, A | 1 |
| Amat, T; Cisneros, JM; Garnacho-Montero, J; Gracia-Ahufinger, I; Gutiérrez-Pizarraya, A; Machuca, I; Pérez-Nadales, E; Torre-Cisneros, J; Torre-Giménez, Á | 1 |
| Bonomo, RA; van Duin, D | 1 |
| Macesic, N; Nelson, B; Uhlemann, AC | 1 |
| Anselmo, A; Di Gregorio, A; Fortunato, A; Gentile, B; Gismondo, MR; Lista, F; Pagani, C; Palozzi, AM; Pittiglio, V; Ridolfo, AL; Rimoldi, SG; Rizzardini, G | 1 |
| Chan, EW; Chen, K; Chen, S; Dong, N; Xie, M; Ye, L | 1 |
| Bandettini, R; Cangemi, G; Castagnola, E; Faraci, M; Gattorno, M; Loy, A; Mesini, A; Moscatelli, A | 1 |
| Cao, J; Hu, Y; Huang, JJ; Jin, Z; Que, CL; Wang, GF; Wang, X; Zhang, H; Zhang, W | 1 |
| Bonnin, RA; Bouallegue, O; Boujaafar, N; Jaidane, N; Jerbi, S; Mansour, W; Naas, T; Radhia, BB | 1 |
| Abdala, E; Cury, AP; da Silva Duarte, AJ; da Silva, AM; Girardello, R; Martins, LF; Morais, C; Rossi, F; Setubal, JC | 1 |
| Barth, AL; Dalmolin, TV; de Lima-Morales, D; Martins, AF; Zavascki, AP | 1 |
| Huang, D; Jacobs, DM; Minhaj, F; Parker, A; Rao, GG; Safir, MC | 1 |
| Berglund, B; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Nilsson, LE; Nilsson, M; Olson, L; Svartström, O; Tärnberg, M; Welander, J | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Pattharachayakul, S; Sakarunchai, I; Santimaleeworagun, W; Singkhamanan, K | 1 |
| Akalın, H; Alışkan, HE; Aydın, G; Aydın, M; Azap, A; Azap, Ö; Başaran, S; Bilgin, H; Çakar, ŞE; Can, F; Çavuş, SA; Demir, NA; Demirkaya, H; Demiroğlu, YZ; Erdinç, Ş; Ergen, P; Ergönül, Ö; Hatipoğlu, Ç; Karakoç, Ç; Karaoğlan, I; Kaya, Ş; Keske, Ş; Memikoğlu, O; Menekşe, Ş; Mülazımoğlu, L; Tekin, S; Tezer, Y; Tümtürk, A; Ural, O; Yardımcı, C; Yılmaz, E | 1 |
| Berglund, B; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Nilsson, LE; Nilsson, M; Olson, L; Tärnberg, M; Welander, J | 1 |
| Guducuoglu, H; Gursoy, NC; Karasin, G; Otlu, B; Parlak, M; Sunnetcioglu, M; Yakupogullari, Y | 1 |
| Baumert, R; Farnleitner, AH; Kirschner, A; Kittinger, C; Lipp, M; Mascher, F; Zarfel, GE | 1 |
| Cao, H; Chow, KH; Ho, PL; Lai, EL; Law, PY; Liu, MC; Wang, Y | 1 |
| Aboklaish, AF; Brovarone, F; Carretto, E; El-Bouseary, MM; Nardini, P; Russello, G; Tyrrell, JM; Walsh, TR | 1 |
| Britto, XB; Gautam, V; Kaur, R; Kumar, SM; Ray, P; Sharma, M; Singhal, L; Verma, S | 1 |
| Chatsuwan, T; Singkham-In, U | 1 |
| Del Bianco, F; Farabegoli, P; Morotti, M; Pedna, MF; Sambri, V | 1 |
| Bonomo, RA; Perez, F | 1 |
| Bonomo, RA; Cober, E; Domitrovic, TN; Hujer, AM; Hujer, KM; Karichu, J; Kaye, KS; Keller, G; Marshall, S; Otiso, J; Perez, F; Richter, SS; Rojas, LJ; Rudin, SD; Salata, R; van Duin, D; Van Heule, H | 1 |
| Katsiari, M; Mavroidi, A; Nikolaou, C; Platsouka, ED | 1 |
| Band, VI; Burd, EM; Farley, MM; Jacob, JT; Satola, SW; Weiss, DS | 1 |
| Alavi-Moghaddam, M; Ghalavand, Z; Goudarzi, H; Houri, H; Nikmanesh, B; Salehi, B | 1 |
| Balloux, F; Bradley, P; Didelot, X; Dorai-Schneiders, T; Iqbal, Z; Jin, L; Liu, Y; Rieux, A; Shaw, LP; van Dorp, L; Wang, H; Wang, Q; Wang, R; Wang, X; Weinert, LA; Zhang, Q | 1 |
| Zavascki, AP | 1 |
| Giacobbe, DR | 1 |
| Carmeli, Y; Daikos, GL; Durante-Mangoni, E; Leibovici, L; Mouton, JW; Paul, M; Theuretzbacher, U | 1 |
| Ebihara, Y; Imai, K; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Sakai, J; Taji, Y; Tarumoto, N; Watanabe, N; Yamaguchi, T | 1 |
| Andini, R; Antoniadou, A; Carmeli, Y; Cavezza, G; Daikos, GL; Dishon Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Leibovici, L; Nutman, A; Paul, M; Pfeffer, I; Skiada, A; Yahav, D; Zak-Doron, Y | 1 |
| Chandar, B; Kumar, R; Parani, M | 1 |
| Chou, SH; Huang, YH; Huang, YW; Liang, SW; Lin, YT; Ni, CE; Yang, TC | 1 |
| Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
| Allard, MW; Anderson, K; Crawford, MA; Fisher, DJ; Hodge, DR; Hughes, MA; Khan, E; Lascols, C; Lomonaco, S; Morse, SA; Pillai, SP; Sharma, SK; Timme, RE | 1 |
| Eiamphungporn, W; Hiranphan, M; Phuadraksa, T; Thamlikitkul, V; Tiengrim, S; Yainoy, S | 1 |
| Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP | 1 |
| Aires-de-Sousa, M; Kieffer, N; Kudyba, P; Nordmann, P; Poirel, L | 1 |
| Kato, A; Kirikae, T; Miyairi, I; Sugahara, Y; Tada, T; Uchida, H | 1 |
| Cai, J; Chan, EW; Chen, S; Dong, N; Hu, Y; Huang, Y; Xie, M; Zhang, R; Zhou, H | 1 |
| Abu Sin, M; Claus, H; Eckmanns, T; Feig, M; Koppe, U; Kroll, LE; Noll, I; Schneider, M; von Laer, A | 1 |
| Cui, M; Gao, Y; Gu, ZC; Zhang, C; Zhang, ZL; Zhao, XY; Zhong, H | 1 |
| Adamou, P; Galani, I; Giamarellou, H; Karaiskos, I; Souli, M | 1 |
| Chavda, B; Chavda, KD; Chen, L; Feng, Y; Hou, M; Kreiswirth, BN; Lv, J; Yu, F | 1 |
| Feng, Y; Lei, S; Liu, W; Mao, J; Sun, J; Wang, W | 1 |
| Choi, CW; Chung, C; Kim, GH; Kim, SI; Lee, H; Lee, JC; Lee, SY; Moon, JY; Oh, MH; Park, EC; Shin, J; Song, HS; Yi, YS; Yun, SH | 1 |
| Büchler, AC; Egli, A; Gehringer, C; Tschudin-Sutter, S; Widmer, AF | 1 |
| Guo, Q; Guo, Y; Li, D; Su, J; Xu, X; Zheng, Y | 1 |
| Cooper, VS; Doi, Y; Ernst, RK; Li, B; Marshall, CW; McElheny, CL; Mettus, RT; Mustapha, MM; Pacey, MP | 1 |
| Florou, Z; Malli, E; Papagiannitsis, CC; Petinaki, E; Stefos, A; Tsilipounidaki, K; Voulgaridi, I; Xitsas, S | 1 |
| Hopkins, KL; Meunier, D; Woodford, N | 1 |
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Amoura, K; Baron, S; Dahi, A; Dandachi, I; Dekhil, M; Diene, SM; Hadjadj, L; Lalaoui, R; Merah, A; Messalhi, N; Rolain, JM; Yousfi, H | 1 |
| Fujita, J; Kirikae, T; Nakasone, I; Shimada, K; Tada, T; Uechi, K | 1 |
| Abdollahi, A; Feizabadi, MM; Haeili, M; Harati, AA; Jabalameli, F; Jafari, S; Jafari, Z; Kardan-Yamchi, J; Meysamie, A | 1 |
| Albornoz, E; Biondi, E; Corso, A; Faccone, D; Gomez, S; Melano, RG; Pasterán, F; Tijet, N; Vazquez, M | 1 |
| Hefzy, EM; Khalil, MAF; Moawad, SS | 1 |
| Andini, R; Antoniadou, A; Ben Dalak Amar, M; Bitterman, R; Carmeli, Y; Daikos, GL; Daitch, V; Dickstein, Y; Dishon Benattar, Y; Durante-Mangoni, E; Friberg, LE; Leibovici, L; Lellouche, J; Mouton, JW; Neuberger, A; Nutman, A; Paul, M; Schwartz, D; Skiada, A; Yahav, D; Zampino, R | 1 |
| Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
| Gaind, R; Jain, M; Rani, V; Sen, MK; Sharma, A; Suri, JC | 1 |
| Dona', D; Ellis, S; Heath, P; Sharland, M; Standing, JF; Thomas, R; Velaphi, S; Walker, AS | 1 |
| Al Zaibag, M; Aljohany, SM; Alothman, AF; Arabi, YM; Baharoon, S; Balkhy, HH; El-Metwally, A; El-Saed, A | 1 |
| Ibrahim, ME | 1 |
| Mobasseri, G; Ooi, PT; Teh, CSJ; Thong, KL | 1 |
| Akkoyunlu, Y; Aslan, T; Daskaya, H; Durdu, B; Hakyemez, IN; Meric Koc, M; Sumbul Gultepe, B | 1 |
| Alharbi, A; Alshehri, S; Eljaaly, K; Ortwine, JK; Pogue, JM | 1 |
| Dawoud, MEE; Eweis, M; Ghaith, D; Hassan, R; Metwally, R; Zafer, M | 1 |
| Band, VI; Burd, EM; Conley, AB; Dumyati, G; Farley, MM; Hardy, DJ; Jacob, JT; Jordan, IK; Rishishwar, L; Satola, SW; Tsay, R; Weiss, DS; Wozniak, JE | 1 |
| De Angelis, M; Garzoli, S; Marzuillo, C; Mastroianni, CM; Oliva, A; Ragno, R; Vullo, V | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Singkhamanan, K; Suphasynth, Y; Wanitsuwan, W | 1 |
| Cuhadar, T; Demirbas Gulmez, Z; Dizbay, M; Guzel Tunccan, O; Kalkanci, A; Ozger, HS; Simsek, H; Unaldi, O; Yildiz, SS | 1 |
| Babaie, Z; Delfani, S; Mahdian, S; Norolahi, F; Rezaei, F; Shakib, P | 1 |
| Al Amin, M; Al Busaidi, I; Al'Adawi, B; Al-Muharrmi, Z; Al-Siyabi, T; Balkhair, A; Hassan, KS; Taher, HB | 1 |
| Baillon-Plot, N; Charbonneau, C; Di Virgilio, R; Falcone, M; Kongnakorn, T; Tichy, E; Wagenlehner, F | 1 |
| Alfonso, C; Berger, MA; Cejas, D; De Paulis, A; Elena, A; Fernández-Canigia, L; Guevara Nuñez, D; Gutkind, G; Magariños, F; Radice, M; Sevillano Platero, P | 1 |
| Agarwal, S; Bhattacharya, A; Garg, A; Garg, J; Kumar, S; Upadhyay, GC | 1 |
| Baron, SA; Peyclit, L; Rolain, JM | 1 |
| Pati, J; Pattnaik, SK; Ray, B; Sahu, S; Sinha, S | 1 |
| Akova, M; Chen, T; Hua, X; Ji, S; Leptihn, S; Pi, B; Xu, Q; Yan, B; Yang, Y; Yu, Y; Zhang, L; Zhou, Z | 1 |
| Goodman, JL; Hartley, DM; Koch, M; Malchione, MD; Torres, LM | 1 |
| Germ, J; Kisek, TC; Nordmann, P; Pirs, M; Poirel, L; Premru, MM; Seme, K; Spik, VC; Zupanc, TL | 1 |
| Ghalavand, Z; Kadkhoda, H; Kodori, M; Maleki, DT; Mohammadzadeh, M; Salehi, B | 1 |
| Çağ, Y; Can, F; Ergonul, O; Hacıseyitoğlu, D; Işık, ME; Menekşe, Ş; Şahin, S | 1 |
| Al Dahouk, S; Kipp, F; Makarewicz, O; Pletz, MW; Stein, C; Vincze, S | 1 |
| Bonelli, RR; de Sousa, VS; Justo-da-Silva, LH; Kraychete, GB; Longo, LGA; Martins, IS; Moreira, BM; Rocha, JA; Superti, SV | 1 |
| Ahmad Kamar, A; Chong, CW; Ngoi, ST; Teh, CSJ; Yap, PSX | 1 |
| Park, SW | 1 |
| Gogry, FA; Haq, QMR; Siddiqui, MT | 1 |
| Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
| Duan, X; Li, S; Peng, Y; Rui, Y | 1 |
| Arsava, EM; Aytaç, H; Bölek, EÇ; Metan, G; Metin, BC; Otlu, B; Tekin, İ; Ünal, S; Zarakolu, P | 1 |
| Das, A; Gaur, M; Rao, EV; Sahoo, RK; Sahoo, S; Subudhi, E | 1 |
| Carmeli, Y; Daikos, G; Dickstein, Y; Durante-Mangoni, E; Friberg, LE; Leibovici, L; Paul, M | 1 |
| Bonomo, RA; Evans, SR; Jiang, Y; Pan, Q; Perez, F; Wilson, BM | 1 |
| Ahn, JY; Choi, H; Choi, JY; Choi, YH; Jeong, SJ; Kim, JM; Ku, NS; Lee, SH; Lim, YS; Shin, SJ; Song, YG; Yeom, JS; Yong, D | 1 |
| Altunin, S; Antoniadou, A; Bernardo, M; Carmeli, Y; Daikos, GL; Daitch, V; Deliolanis, I; Dickstein, Y; Dishon Benattar, Y; Durante-Mangoni, E; Friberg, LE; Iossa, D; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Rakovitsky, N; Rognås, V; Schwartz, D; Skiada, A; Yahav, D | 1 |
| Ardebili, A; Ezadi, F; Heidari, A; Jamali, A; Javid, N | 1 |
| Nishida, S; Ono, Y | 1 |
| Feng, Y; Liu, L; Ma, K; Yao, Z; Zong, Z | 1 |
| Anastassiou, ED; Assimakopoulos, SF; Christofidou, M; Fligou, F; Karamouzos, V; Kolonitsiou, F; Marangos, M; Papachristou, E; Papadimitriou-Olivgeris, M; Solomou, A; Spiliopoulou, I; Spyropoulou, A; Vamvakopoulou, S | 1 |
| Gao, GF; Hu, Y; Liu, F; Wang, Y; Zhang, G; Zhu, B | 1 |
| Dudeja, S | 1 |
| Chang, JS; Chien, HT; Hsieh, KP; Lin, YC; Sheu, CC | 1 |
| Abad, CLR; Li, KL | 1 |
| Bardhan, T; Bhattacharjee, B; Chakraborty, M | 1 |
| Azeem, F; Khurshid, M; Naeem, M; Nisar, MA; Qamar, MU; Rasool, MH; Saqalein, M; Sarfraz, M; Shahzad, A; Siddique, MH; Sohail, M; Taj, Z | 1 |
| Abramov, S; Amar Ben Dalak, M; Carmeli, Y; Elmaliach, N; Kon, H; Lellouche, J; Schwartz, D | 1 |
| Baron Sophie, A; Bournia, M; Charalampaki, N; Chatzipanagiotou, S; Christofidou, M; Fountoulis, K; Hadjadj, L; Hamel, M; Ioannidis, A; Kraniotaki, H; Legakis, N; Papagianni, S; Papaioannou, V; Papamichalopoulos, N; Perivolioti, E; Petinaki, E; Rolain, JM; Skalidis, T; Skarmoutsou, N; Spiliopoulou, I; Tsiplakou, S | 1 |
| Ghafur, A; Krishnan, P; Palani, GS; Rayvathy, B; Thirunarayan, MA | 1 |
| Ashraf, A; Atrkar Roushan, Z; Khanjani, S; Mojtahedi, A; Sedigh Ebrahim-Saraie, H; Shenagari, M | 1 |
| Andini, R; Antoniadou, A; Bitterman, R; Brill, MJE; Carmeli, Y; Daikos, GL; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Friberg, LE; Karlsson, MO; Kotsaki, A; Kristoffersson, AN; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Rognås, V; Skiada, A; Theuretzbacher, U | 1 |
| Earl, A; Hagmann, S; Kelly, P; Knouse, M; LaRocque, RC; Leung, DT; Mellon, G; Oliver, E; Ryan, ET; Turbett, SE; Walker, AT; Walters, M; Worby, C | 1 |
| Bernardo, M; Bitterman, R; Carmeli, Y; Daikos, G; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Friberg, LE; Iossa, D; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Skiada, A; Temkin, E; Theuretzbacher, U; Yahav, D; Zusman, O | 1 |
| Chang, FY; Chiu, SK; Huang, LY; Lin, JC; Lin, YT; Siu, LK; Tsai, YK; Wang, CH | 1 |
| Karakonstantis, S | 1 |
| Albers, AL; Ballash, GA; Feicht, SM; Lee, J; Lee, S; Mathys, DA; Mollenkopf, DF; Sechrist, E; Sullivan, SMP; Van Balen Rubio, JC; Wittum, TE | 1 |
| Fan, X; Fu, Y; Li, C; Li, J; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Abulaila, A; Aktas, Z; Erdem, F; Oncul, O | 1 |
| Carmeli, Y; Nutman, A | 1 |
| Das, A; Dey, S; Gaur, M; Jain, B; Pati, S; Sahoo, RK; Subudhi, E | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S | 1 |
| Higgins, PG; Kresken, M; Miller, A; Müller, C; Seifert, H; Stefanik, D | 1 |
| Barquist, L; Blaskovich, MAT; Boinett, CJ; Butler, MS; Cain, AK; Cooper, MA; Edwards, IA; Elliott, AG; Huang, JX; Lociuro, S; Lundberg, CV; Mobli, M; Neve, S; Porter, KM; Steen, J; Strandh, M; Zuegg, J | 1 |
| Choi, YK; Jeon, J; Lee, J; Park, JJ; Seo, YB | 1 |
| Sfeir, MM | 1 |
| Han, S; Hong, CK; Kim, HS; Kim, J; Kim, JS; Lee, SM; Oh, YH; Park, J; Park, SH; Yu, JK | 1 |
| Fournier, C; Nordmann, P; Poirel, L | 1 |
| Brito, JCM; da Cruz Nizer, WS; Lima, WG | 1 |
| Cuba, GT; Ramos, JF; Veiga Kiffer, CR | 1 |
| Chanawong, A; Charoensri, N; Faksri, K; Lulitanond, A; Lunha, K; Ngudsuntia, A; Tavichakorntrakool, R; Thet, KT; Wonglakorn, L | 1 |
| Kois, AK; Kuti, JL; Nicolau, DP | 1 |
| Hao, Q; Ho, PL; Kao, RY; Li, H; Sun, H; Wang, H; Wang, M; Wang, R; Wong, YT; Yan, A; Zhang, Q | 1 |
| Bishop, BM; Hitt, SJ; van Hoek, ML | 1 |
| Alabaz, D; Gündeşlioğlu, ÖÖ; Haytoğlu, Z; Horoz, ÖÖ; Kocabaş, E; Yıldızdaş, D | 1 |
| Bonnin, RA; Cabanel, N; Chiarelli, A; Glaser, P; Naas, T; Rosinski-Chupin, I; Zongo, PD | 1 |
| Cai, C; Li, Y; Shen, J; Shen, Z; Shi, X; Walsh, TR; Wang, S; Wang, Y; Wu, Y; Yang, Y | 1 |
| Hazırolan, G; Karagöz, A | 1 |
| Al Fadhli, AH; Jamal, WY; Rotimi, VO | 1 |
| Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A | 1 |
| Alves, EG; Faria-Junior, C; Lima, GRCEC; Nery, DR; Oliveira, PM; Pereira, AL; Silva, DMD; Silva, LOR | 1 |
| Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S; Yoodee, J | 1 |
| Feng, Y; McNally, A; Zong, Z | 1 |
| Dhandapani, S; Gunalan, A; Manoharan, M; Sastry, AS; Sistla, S; Sugumar, M | 1 |
| Chan, MC; Chen, CM; Feng, JY; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR | 1 |
| Beatson, SA; Hancock, SJ; Harris, PNA; Phan, MD; Roberts, LW; Schembri, MA; Vu, TNM | 1 |
| Ani Caovilla Follador, F; Carolina Lucio, L; Elize Defante Ferreto, L; Fiorentin Vandresen, D; Paula Vieira, A; Pereira Bento Casaril, K; Pitt Benedetti, V; Shigueyasu Yamada, R; Viviane Buzanello Martins, C; Welter Wendt, G | 1 |
| Caierão, J; Collar, GS; da Cunha, GR; da Silva, RMC; Dias, C; Mott, MP; Raro, OHF; Riche, CVW; Vezzaro, P | 1 |
| Babar, ZU; Dodani, SK; Nasim, A | 1 |
| Chomnawang, MT; Houngsaitong, J; Kanathum, P; Khuntayaporn, P; Montakantikul, P; Thirapanmethee, K | 1 |
| Adler, A; Andini, R; Antoniadou, A; Babich, T; Ben-Zvi, H; Benattar, YD; Bitterman, R; Carmeli, Y; Cavezza, G; Daikos, GL; Daitch, V; Dickstein, Y; Durante-Mangoni, E; Eliakim-Raz, N; Friberg, LE; Koppel, F; Leibovici, L; Levi, I; Mouton, JW; Nutman, A; Paul, M; Pavleas, I; Skiada, A; Theuretzbacher, U; Turjeman, A; Yahav, D; Zak-Doron, Y; Zampino, R; Zayyad, H; Zusman, O | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Chen, WY; Cheng, YH; Chou, SH; Chuang, C; Huang, PH; Juan, CH; Lin, YT; Wang, FD; Wang, JT | 1 |
| Blakeway, LV; Hawkey, J; Holt, KE; Jenney, AW; Judd, LM; Macesic, N; Peleg, AY; Stewart, JD; Wick, RR; Wyres, KL | 1 |
| Alkan, M; Ankaralı, H; Arsu, HY; Aygün, G; Balkan, II; Biçer, M; Karaali, R; Karagöz, A; Kaya, SY; Kuşkucu, M; Mete, B; Saltoğlu, N; Şen, S; Tabak, F | 1 |
| Karpov, IA; Osipkina, OV; Petrovskaya, TA; Tapalski, DV; Timoshkova, EV | 1 |
| Han, S; Hwang, YO; Jang, JI; Jeon, SJ; Kang, M; Kim, JS; Kwon, MJ; Lee, JH; Oh, YH; Park, SH; Yu, JK | 1 |
| Baldissera, GS; Mathos, D; Rigatto, MH; Rodrigues, D; Sartori, A; Zavascki, AP | 1 |
| Cao, J; Chen, L; Fang, R; Huang, N; Liu, S; Yu, K; Zhang, Y; Zhou, C; Zhou, T | 1 |
| Chang, TH; Chang, YH; Chen, CC; Chen, WY; Chen, YC; Chou, Y; Chuang, YC; Hsu, WY; Tang, HJ | 1 |
| Kao, TC; Li, TC; Lin, CT; Sun, MF; Tseng, CY | 1 |
| Al-Bayssari, C; El Hamoui, S; Fenianos, F; Makdissy, N; Nasreddine, N; Nawfal Dagher, T; Rolain, JM | 1 |
| Beloeil, PA; Bortolaia, V; Guerra, B; Hansen, IM; Hendriksen, RS; Hoffmann, M; Kjeldgaard, JS; Leekitcharoenphon, P; Milita, NM; Mordhorst, H; Nicorescu, I; Romascu, L; Ronco, T; Svendsen, CA; Vaduva, AM | 1 |
| Castaño, GN; Lemos, E; Reyes, JM; Varón-Vega, FA | 1 |
| Angkititrakul, S; Chuanchuen, R; Lee, S; Prathan, R; Pungpian, C; Sinwat, N; Srisanga, S; Trongjit, S | 1 |
| Chan, EW; Chen, S; Dong, N; Li, R; Liu, X; Ye, L | 1 |
| Aziz, MA; Matar, GM; Moghnieh, RA; Moussa, JA | 1 |
| Feng, H; He, L; Wu, H; Xu, P; Zhang, H | 1 |
| Al-Mir, H; Drapeau, A; Haenni, M; Hamze, M; Madec, JY; Osman, M | 1 |
| Bozdogan, B; Guney, M; Guney-Kaya, K; Hosbul, T; Oryasin, E; Sakarya, S | 1 |
| Al Sanabani, SS; Costa, SF; Guimarães, T; Leite, G; Levin, AS; Martins, RCR; Ramos, JF; Rizek, C; Rocha, V; Rossi, F | 1 |
| Badmasti, F; Bolourchi, N; Giske, CG; Nematzadeh, S; Noori Goodarzi, N; Shahcheraghi, F; Solgi, H | 1 |
| Bakry, U; Diab, AA; El-Shqanqery, HE; Elanany, M; Elzayat, MG; Hassan, R; Jalal, D; Samir, O; Sayed, AA; Shalaby, L | 1 |
| Akamatsu, N; Izumikawa, K; Kaku, M; Kaku, N; Kawamoto, Y; Kosai, K; Mikamo, H; Morinaga, Y; Ohmagari, N; Oishi, K; Sakamoto, K; Yamamoto, Y; Yanagihara, K | 1 |
| Evans, CT; Fitzpatrick, MA; Patel, U; Poggensee, L; Suda, KJ; Traversa, A; Wilson, GM | 1 |
| de Lacerda Bonfante, H; Gontijo, AVL; Pereira, SL | 1 |
| Andersson, DI; Bower, CW; Davis, M; Howard-Anderson, J; Jacob, JT; Page, AM; Satola, SW; Smith, G; Weiss, DS | 1 |
| Caldwell, B; Hamprecht, A; Henriksen, AS; Longshaw, C; Thelen, P; Yamano, Y | 1 |
| Ben Chehida, F; Bouslama, M; Daaloul-Jedidi, M; Lahmar, S; Mamlouk, A; Messadi, L; Selmi, R; Srairi, S; Tayh, G | 1 |
| Boll, JM; Carlson, EE; Cattoir, V; Cross, T; Dörr, T; Fihn, C; Kazi, MI; Murtha, AN; Schargel, RD | 1 |
| Gao, Y; Guo, L; Guo, S; Jing, N; Li, Y; Shi, C; Wei, X; Yan, W; Yuan, Y; Zhang, Q; Zhao, L; Zhao, W | 1 |
| Farajzadeh Sheikh, A; Farshadzadeh, Z; Hashemzadeh, M; Heidari, R; Saki, M; Salmanzadeh, S | 1 |
| Naknaen, A; Phaonakrop, N; Pomwised, R; Roytrakul, S; Smith, DR; Surachat, K; Voravuthikunchai, SP; Wintachai, P | 1 |
| Chan, EW; Chen, K; Chen, S; Dong, N; Xie, M; Xu, Q; Zhang, R | 1 |
| Akcan, RE; Akyol, M; Barçın, E; Can, F; Demirlenk, YM; Ergönül, Ö; Gönen, M; Gücer, LS; Kalay, Z; Tanrıöver, C; Uçku, D | 1 |
| Ambretti, S; Antonelli, A; Bartoletti, M; Bassetti, M; Bussini, L; Cavallo, R; Coppi, M; Corcione, S; De Rosa, FG; Dettori, S; Gaibani, P; Giacobbe, DR; Giani, T; Giannella, M; Lewis, R; Marchese, A; Marconi, L; Pascale, R; Rossolini, GM; Shbaklo, N; Viale, P | 1 |
| Barnini, S; Della Sala, L; Falcone, M; Farcomeni, A; Leonildi, A; Menichetti, F; Tiseo, G; Vecchione, A | 1 |
| Chen, Y; Du, B; Huang, HB; Peng, JM; Weng, L | 1 |
| Chan, MC; Chen, CM; Chen, WC; Chou, YC; Feng, JY; Peng, CK; Sheu, CC; Wang, SH; Wu, BR; Yang, KY; Zheng, ZR | 1 |
| Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S | 1 |
| Amatya, P; Baker, S; Basnyat, B; Dixit, SM; Dongol, S; Karkey, A; Manandhar, S; Nguyen, Q; Pham, DT; Rabaa, M | 1 |
| Albay, A; Aydoğan, CN; Bedir, O; Gümral, R; Hoşbul, T; Kaya, S | 1 |
| Cicioğlu Arıdoğan, B; Köle, M; Sesli Çetin, E; Şirin, MC | 1 |
| Chan, MC; Chen, CM; Chen, CY; Feng, JY; Liang, SJ; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR | 1 |
| Ju, YG; Lee, HJ; Lee, MG; Sohn, JW; Yim, HS; Yoon, YK | 1 |
| Acín, P; Grau, S; Luque, S; Sorli, L | 1 |
| Adhikari, P; Paudel, S; Shah, PK; Singh K C, S; Thapa Shrestha, U | 1 |
| Baykara, B; Cimentepe, M; Kandemir, T; Koksal, F | 1 |
| Gong, X; Jiang, X; Shen, Z; Wang, X; Wang, Y | 1 |
| Chen, X; Jiang, J; Li, P; Su, J; Sun, Z; Xu, X | 1 |
| Adamczyk, M; Ansari, U; Babiker, A; Bower, C; Breaker, E; Howard-Anderson, J; Jacob, JT; Lutgring, JD; McAllister, G; Petit, RA; Satola, SW; Woodworth, MH | 1 |
| Aguirre, C; Conza, JAD; Lösch, LS; Lovera, LMR; Merino, LA; Pellegrini, JL; Soto, SM | 1 |
| Nakano, A; Nakano, R; Ogawa, M; Saito, K; Sakata, R; Suzuki, Y; Tanouchi, A; Watanabe, M; Yano, H | 1 |
| Aseffa, A; Asrat, D; Hasan, B; Legese, MH; Mekasha, A; Mihret, A; Swedberg, G | 1 |
| Alyafawi, DA; Elnasser, ZA; Gharaibeh, MH; Lafi, SQ; Obeidat, HM | 1 |
| Ozturk, S | 1 |
| Abe, S; Amarasiri, M; Aryukarn, A; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Hao, LY; Higgins, PG; Hongsing, P; Hurst, C; Kicic, A; Kueakulpattana, N; Kupwiwat, R; Laowansiri, M; Leelahavanichkul, A; Liao, T; Luk-In, S; Ngamwongsatit, N; Nilgate, S; Ounjai, P; Phattharapornjaroen, P; Ragupathi, NKD; Rirerm, U; Saethang, T; Shein, AMS; Srisakul, S; Techawiwattanaboon, T; Wannigama, DL; Yonpiam, M | 1 |
| Cai, C; Chan, EW; Chen, S; Dong, N; Ju, X; Li, R; Li, Y; Liu, C; Lu, J; Shen, Z; Wang, S; Wu, Y; Zhang, R; Zhou, H | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Archer, E; Botes, M; Bröcker, L; Carstens, A; Feil, EJ; Kasprzyk-Hordern, B; Mageiros, L; Meric, G; Mourkas, E; Nel, D; Pascoe, B; Sheppard, SK; Smith, K; Tucker, K; Wolfaardt, G | 1 |
| Bonnin, RA; Pfeifer, E; Rocha, EPC | 1 |
| Hayashi, C; Kai, D; Kamoshida, G; Kanda, N; Kaya, Y; Morimoto, H; Nakamura, T; Okada, T; Sakaguchi, M; Sawada, T; Takemoto, N; Yahiro, K; Yamada, N; Yamaguchi, D; Yamashita, M | 1 |
| Akalin, H; Ener, B; Özakin, C; Payaslioğlu, M; Ülkü Tüzemen, N | 1 |
| Gao, Z; Guan, J; He, Y; Li, Y; Ma, X; Ni, W; Wang, Y; Zhao, J | 1 |
| Lowe, M; Perovic, O; Shuping, L | 1 |
| Grafl, B; Hess, C; Hess, M; Maegdefrau, M | 1 |
| Chang, SK; Cheng, WH; Lai, KS; Lim, SE; Yap, PS | 1 |
| Abu-Taleb, R; Alamneh, YA; Bushnell, RV; Czintos, CM; Daly, MJ; Dollery, SJ; Escatte, MG; MacLeod, DA; Meeks, HN; Su, W; Tasker, NJPER; Tobin, GJ; Tobin, JK; Wiggins, TJ; Zurawski, DV | 1 |
| Leshaba, TMS; Mbelle, NM; Mmatli, M; Osei Sekyere, J; Skosana, LB | 1 |
| Guery, B; Jacot, D; Papadimitriou-Olivgeris, M | 1 |
| Choi, JG; Kim, JH; Kim, YS; Lee, EK; Lee, SW; Lee, W; Park, IH; Ryu, EJ; Yoon, JW | 1 |
| Boueroy, P; Chopjitt, P; Hatrongjit, R; Jenjaroenpun, P; Jittapalapong, S; Kerdsin, A; Wongsurawat, T | 1 |
| Dong, Y; Ed-Dra, A; Lin, H; Lin, J; Ma, J; Tang, B; Wu, J; Yang, H; Yue, M | 1 |
| Abdul Hak, A; El Swify, M; El-Mahallawy, HA; Zafer, MM | 1 |
| Abusalah, MAHA; Ahmed, N; Al-Adsani, W; Al-Jishi, JM; Alabdullah, DM; Albayat, H; Alfaraj, AH; Alhajri, M; Alhumaid, S; Almuhtaresh, HA; Almushrif, SA; Alshiekheid, MA; Alwarthan, S; Eljaaly, K; Garout, M; Khamis, F; Livias, KA; Mohammed, EAE; Mutair, AA; Rabaan, AA; Sabour, AA; Tombuloglu, H; Yami, FSA | 1 |
| Goy, K; Luna, B; Miller, S; She, R; Spellberg, B | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Afridi, FI; Baig, S; Jamal, Q; Khan, R; Sani, AI; Zaidi, SAA | 1 |
| Chan, MC; Chen, CM; Chen, CY; Chou, YC; Feng, JY; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR | 1 |
| Chen, CH; Ho, MW; Hsueh, PR; Lu, MC; Wu, PH | 1 |
| Dalğıç, D; Kandemir, T; Nağıyev, T; Üçkayabaşı, A | 1 |
| Cao, B; Li, Z; Lu, B; Pu, D; Wu, Y; Zhang, Y; Zhao, J; Zhuo, X | 1 |
| Kiran, GS; Prabhakaran, A; Rajeev, R; Seethalakshmi, PS; Selvin, J | 1 |
| Ardebili, A; Izanloo, A; Rastegar, M | 1 |
| Eidi, M; Hejazi, SH; Mohammadi, M; Motallebi, M; Saffari, M; Shayestehpour, M; Siadat, SD | 1 |
| Barmudeh, S; Batignani, V; Cirillo, DM; Ghodousi, A; Haeili, M; Kafil, HS; Omrani, M; Zeinalzadeh, N | 1 |
| Akca, G; Drcelic, M; Goic-Barisic, I; Hrenovic, J; Jakovac, S; Music, MS; Tonkić, M; Tuncbilek, S | 1 |
| Akcam, FZ; Cetin, ES; Gonen, I; Kaya, O; Ozturk, T; Temel, EN; Unal, O | 1 |
| Ang-Kucuker, M; Bayirli-Turan, D; Gumus, D; Gun, G; Kalayci-Yuksek, F; Macunluoglu, AC; Nakipoglu, Y; Uyanik-Ocal, A | 1 |
| Berglund, B; Li, Q; Li, X; Meng, M; Wang, D; Zhao, L; Zou, H | 1 |
| Chen, WC; Cho, CF; Cho, DY; Ho, LC; Ho, MW; Hsieh, YW; Hsu, KC; Hsueh, PR; Huang, JY; Liang, SJ; Lin, HH; Lin, YT; Tien, N; Tseng, KH; Yu, J | 1 |
| Britto, AY; Goodman, JL; Hartley, DM; Koch, M; Malchione, MD; Venne, DM | 1 |
| Mitchell, RJ; Mun, W; Upatissa, S | 1 |
| Bleick, C; Caniff, K; El-Ghali, A; Kunz Coyne, AJ; Rybak, MJ | 1 |
| Gao, F; Lei, T; Liang, B; Su, J; Tan, Y; Zeng, H | 1 |
| Borrazzo, C; Bruni, A; Garofalo, E; Gullì, S; Lionello, R; Longhini, F; Marascio, N; Matera, G; Quirino, A; Romeo, F; Russo, A; Serapide, F; Serraino, R; Torti, C; Trecarichi, EM | 1 |
| Bac, NH; Diep, DTH; Dung, TTN; Duyen, BTH; Ngoc, KM; Nguyen, Q; Nien, LV; Pham, DT; Phat, VV; Phung, CT; Rabaa, MA; Tam, DTH; Thwaites, G; Tuan, HM; Tuan, TD; Vinh, C | 1 |
| Paterson, DL; Shields, RK; Tamma, PD | 1 |
| Altarac, D; Du, B; Isaacs, R; Watkins, RR | 1 |
| Aird, H; Cawthraw, S; Chattaway, M; Jørgensen, F; Kesby, M; Lai, S; Lock, I; Quill, E; Raykova, G; Willis, C | 1 |
| Aboalgasem, MO; Alrjael, JF; Amhalhal, JMA; Chouchani, C; Diene, SM; Dziri, O; Mathlouthi, N; Mohamed, EA; Rolain, JM; Salabi, AE; Slimene, K | 1 |
| Cheng, J; Jin, J; Li, G; Li, L; Shao, H; Song, Y; Sun, Y; Wang, L; Wang, S; Zhang, Y | 1 |
| Bernardo, M; Carmeli, Y; Daikos, GL; Daitch, V; Dickstein, Y; Dishon Benattar, Y; Durante-Mangoni, E; Friberg, LE; Hameir, A; Iossa, D; Kaye, KS; Keren Paz, A; Kon, H; Leibovici, L; Lellouche, J; Mendelsohn, S; Nutman, A; Paul, M; Pollak, D; Schwartz, D; Skiada, A; Temkin, E; Theuretzbacher, U; Weiss, DS; Yahav, D | 1 |
| Shah, BK; Wang, C; Wang, J; Xie, S; Xiong, J; Zhao, J | 1 |
| Huang, E; Leighton, E; Li, X; Yang, X | 1 |
| Han, X; Hu, H; Jiang, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhang, P; Zhao, D | 1 |
| Maraolo, AE; Ong, DSY | 1 |
| Katip, W; Nampuan, T; Oberdorfer, P; Rayanakorn, A; Taruangsri, P | 1 |
| Dai, X; Fang, C; Li, Y; Qiu, Y; Zhang, L | 1 |
| Allel, K; Araos, R; Arias, CA; Conejeros, J; García, P; Lessa, FC; Martínez, JRW; McGovern, O; Munita, JM; Orellana Chea, C; Patel, TS; Peters, A; Riquelme-Neira, R; Rivas, L; Rojas, P; Spencer-Sandino, M; Undurraga, EA | 1 |
| Ahmed, D; Bollinger, S; Chowdhury, F; Hassan, MZ; Hossain, K; Khan, AA; Luvsansharav, UO; Mah-E-Muneer, S; Mozumder, P; Rahman, M; Sarker, M; Sen, D; Sharma, A; Smith, RM; Styczynski, A; Vanderende, D | 1 |
| Chen, L; Du, H; Huang, B; Jia, W; Qu, F; Shan, B; Tang, Y; Wang, T; Weng, Y; Yu, H | 1 |
| Borghi, M; Pereira, MF; Schuenck, RP | 1 |
| Ghavidel, M; Ghazvini, K; Khoshbakht, R; Neshani, A; Panahi, S | 1 |
| Lukovic, B; Petrovic, I; Zornic, S | 1 |
| Cai, J; Chen, C; Liu, Y; Shi, J; Wang, Z | 1 |
| Lakshmanan, D; Ramasamy, D; Saravanan, SK; Subramanyam, V | 1 |
| Hishinuma, T; Htoon, TT; Kirikae, T; Oshiro, S; Tada, T; Tin, HH; Tohya, M; Watanabe, S | 1 |
| Aygen, B; Bolat, D; Dinc, G; Eren, EE; Gönen, ZB; İzci, F; Ture, Z; Ünüvar, GK; Yay, AH; Yıldız, O | 1 |
| Chambers, HF; Cross, HR; Evans, SR; Fowler, VG; Patel, R; Souli, M | 1 |
| Chen, L; Chen, S; Du, H; Qu, F; Wang, T; Wang, X; Zhu, J; Zhu, Z | 1 |
| Gong, F; Liu, J; Lu, L; Shao, Z; Shi, K; Tang, S; Zheng, Z | 1 |
| Copur Cicek, A; Ejder, N; Ibik, YE; Rakici, E; Sevim, E; Tanriverdi, ES | 1 |
| Bolukaoto, JY; Musyoki, AM; Nchabeleng, M; Nkawane, GM; Nogbou, ND; Phofa, TD; Ramashia, M | 1 |
| Ak, K; Arabacı, Ç; Arı, O; Büyüktuna, SA; Çetin, ES; Çetinkaya, RA; Dal, T; Durmaz, R; Hasbek, M; Kaynar, T; Köse, Ş; Külahlıoğlu, N; Müderris, T; Şahin, M; Sarı, T; Temel, EN; Yalçın, AN; Yenilmez, E; Yıldırım, BT | 1 |
| Chomnawang, MT; Khuntayaporn, P; Thirapanmethee, K; Wanapaisan, P; Wiradiputra, MRD | 1 |
| Alharbi, N; Kadaikunnan, S | 1 |
48 review(s) available for carbapenems and colistin
| Article | Year |
|---|---|
Current therapies for pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic | 2008 |
Management of antibiotic-resistant infection in the newborn.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Carrier State; Colistin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Europe; Gene Transfer, Horizontal; Humans | 2012 |
Colistin: new lessons on an old antibiotic.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2012 |
The rise of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation; Humans; Immunocompromised Host | 2013 |
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Rifampin; Risk Factors; Tigecycline | 2013 |
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Minocycline; Tigecycline | 2013 |
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disease Management; Disease Outbreaks; Epidemiological Monitoring; Humans; Minocycline; Tigecycline | 2013 |
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline | 2013 |
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Critical Illness; Drug Therapy, Combination; Enterobacteriaceae; Humans; Minocycline; Pneumonia, Bacterial; Survival Analysis; Tigecycline; Urinary Tract Infections | 2014 |
Options for treating carbapenem-resistant Enterobacteriaceae.
Topics: beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Practice Patterns, Physicians'; Prospective Studies; Retrospective Studies; Tigecycline; Treatment Outcome | 2014 |
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Therapy, Computer-Assisted; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Risk Factors; Tigecycline | 2015 |
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulbactam; Tigecycline | 2015 |
Strategies for the safe use of colistin.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance; Gram-Negative Bacteria; Humans; Kidney Diseases | 2015 |
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Colistin; Critical Illness; Drug Combinations; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Retrospective Studies; Thienamycins | 2016 |
Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Iran; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Rifampin; Thienamycins; Tigecycline | 2017 |
Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Infant, Newborn | 2017 |
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Pneumonia; Polymyxin B; Polymyxins; Tigecycline; Treatment Outcome; Urinary Tract Infections | 2017 |
Treatment Options for Carbapenem- Resistant Gram-Negative Infections.
Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline | 2018 |
Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Patient Safety; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2018 |
The use of polymyxins to treat carbapenem resistant infections in neonates and children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Infant, Newborn; Polymyxin B; Polymyxins | 2019 |
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Risk Factors; Saudi Arabia | 2019 |
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Colistin; Dose-Response Relationship, Drug; Drug Approval; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Randomized Controlled Trials as Topic; Sisomicin; United States; United States Food and Drug Administration; Urinary Tract Infections | 2019 |
Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Databases, Factual; Drug Combinations; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans | 2019 |
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia, Southeastern; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Genotype; Humans; Infant; Infant, Newborn; Klebsiella Infections; Male; Middle Aged; Young Adult | 2019 |
Neonatal Sepsis: Treatment of Neonatal Sepsis in Multidrug-Resistant (MDR) Infections: Part 2.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood Culture; Carbapenems; Colistin; Drug Resistance, Multiple; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Neonatal Sepsis | 2020 |
Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Renal Replacement Therapy | 2020 |
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotyping Techniques; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2020 |
A plethora of carbapenem resistance in
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines | 2021 |
Carbapenem and Colistin Resistance in Enterobacter: Determinants and Clones.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Humans; Microbial Sensitivity Tests | 2021 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq.
Topics: Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Iraq; Jordan; Lebanon; Microbial Sensitivity Tests | 2021 |
Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2021 |
A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tigecycline | 2022 |
Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis | 2022 |
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Permeability | 2022 |
An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Genotype; Humans | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
The menace of colistin resistance across globe: Obstacles and opportunities in curbing its spread.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Humans | 2023 |
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B; Polymyxins; Retrospective Studies; Rifampin | 2023 |
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella; Microbial Sensitivity Tests; Polymyxins | 2023 |
Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Colistin; Humans; Lactams; United States | 2023 |
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Sulbactam | 2023 |
Carbapenem resistance in the food supply chain.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Food Supply; Humans; Microbial Sensitivity Tests; Tigecycline | 2023 |
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bayes Theorem; Carbapenems; Colistin; Humans; Meropenem; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 2023 |
Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Quorum Sensing | 2023 |
Mobile colistin resistance (mcr) genes and recent developments in colistin resistance detection.
Topics: Anti-Bacterial Agents; Carbapenems; Cell Wall; Colistin | 2023 |
The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Colistin; Drug Resistance, Bacterial; Humans; Leadership; Microbial Sensitivity Tests | 2023 |
13 trial(s) available for carbapenems and colistin
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Colistin; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Groin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pharynx; Rectum; Urine | 2012 |
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome | 2013 |
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome | 2014 |
Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Feces; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Prospective Studies; Thienamycins | 2015 |
Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.
Topics: Acinetobacter baumannii; Adult; Bacteremia; Carbapenems; Colistin; Disease-Free Survival; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Male; Pneumonia, Ventilator-Associated; Prospective Studies; Survival Rate | 2016 |
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Treatment Outcome | 2018 |
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Data Interpretation, Statistical; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2019 |
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests | 2020 |
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans | 2020 |
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes.
Topics: Aged; Aged, 80 and over; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2020 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulbactam | 2023 |
417 other study(ies) available for carbapenems and colistin
| Article | Year |
|---|---|
Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Brain Diseases; Carbapenems; Central Nervous System Bacterial Infections; Cerebral Ventricles; Colistin; Drug Resistance, Microbial; Encephalitis; Female; Humans; Injections, Intraventricular; Male; Middle Aged; Treatment Outcome | 1999 |
Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cluster Analysis; Colistin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; United Kingdom | 2002 |
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin | 2004 |
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Rifampin; Treatment Outcome | 2005 |
Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Electrophoresis, Gel, Pulsed-Field; Humans; Integrases; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Population Surveillance; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sulbactam; Tigecycline | 2007 |
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Disease Outbreaks; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hand Disinfection; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Risk Factors; Suction | 2007 |
Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; False Positive Reactions; Humans; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Italy; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2007 |
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Blood; Carbapenems; Cohort Studies; Colistin; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillins; Quinolones; Retrospective Studies; Risk Factors | 2007 |
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Korea; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome | 2008 |
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome | 2009 |
[Bacterial death and heteroresistance to antimicrobial agents].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Indicator Dilution Techniques; Microbial Sensitivity Tests; R Factors; Selection, Genetic; Staphylococcus aureus; Trans-Activators; Virulence | 2008 |
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome | 2009 |
Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Time Factors; Trachea | 2009 |
[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Turkey | 2009 |
Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Imipenem; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Sulbactam; Thienamycins | 2010 |
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2010 |
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2010 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction | 2010 |
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2011 |
Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2011 |
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Organ Transplantation; Transplantation; Treatment Outcome | 2011 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.
Topics: Adult; Aztreonam; beta-Lactamases; Carbapenems; Colistin; Female; Gentamicins; Greece; Humans; Klebsiella pneumoniae; Medical Tourism; Minocycline; Plasmids; Tigecycline | 2011 |
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hospital Mortality; Humans; Infant; Length of Stay; Male; Michigan; Middle Aged; Minocycline; Nursing Homes; Retrospective Studies; Tigecycline; Treatment Outcome; Young Adult | 2011 |
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Half-Life; Humans; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins | 2012 |
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors | 2012 |
In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thailand; Time Factors | 2011 |
Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Prevalence; Respiratory Tract Infections; Retrospective Studies; Syria; Urinary Tract Infections; Young Adult | 2012 |
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Combinations; Drug Interactions; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cohort Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Minocycline; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tigecycline; Treatment Outcome | 2012 |
Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa.
Topics: Aged; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Nephrolithiasis; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Tract Infections | 2011 |
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Tigecycline | 2012 |
Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, General; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patients' Rooms; Polymerase Chain Reaction | 2012 |
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.
Topics: Adult; Aged; Carbapenems; Colistin; Contact Tracing; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genome, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; United States; Young Adult | 2012 |
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Female; Gentamicins; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome | 2013 |
Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriuria; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Colistin; Confidence Intervals; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Urinary Catheters; Young Adult | 2013 |
Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Urban Population; Young Adult | 2013 |
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Larva; Lipid A; Microbial Sensitivity Tests; Moths; Signal Transduction; Vancomycin | 2013 |
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biomarkers, Pharmacological; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline | 2013 |
Effect of pulmonary surfactant on antimicrobial activity in vitro.
Topics: Acetamides; Animals; Anti-Infective Agents; Aza Compounds; Carbapenems; Colistin; Daptomycin; Doripenem; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Oxazolidinones; Pulmonary Surfactants; Quinolines; Staphylococcus aureus; Swine; Tigecycline | 2013 |
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multivariate Analysis; Mutation; Porins; Promoter Regions, Genetic | 2013 |
Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Methylprednisolone; Methylprednisolone Acetate; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Structure-Activity Relationship; Tigecycline | 2014 |
Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple; Evolution, Molecular; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Mutation Rate; Sequence Analysis, DNA | 2014 |
Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Meningoencephalitis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Surgical Wound Infection; Treatment Outcome | 2014 |
[Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Turkey | 2013 |
Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Sulbactam | 2014 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Spain; Survival Analysis; Tigecycline | 2014 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.
Topics: Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Prospective Studies; Risk Factors | 2013 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Sulbactam; Treatment Outcome | 2014 |
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
Topics: Algorithms; Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Genotype; Gentamicins; Glycine; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Porins | 2014 |
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Tigecycline; Treatment Outcome; Young Adult | 2014 |
Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Sicily | 2014 |
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Moths; Tigecycline | 2014 |
Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Critical Illness; Croatia; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Survival Analysis | 2014 |
Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Colony Count, Microbial; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 2014 |
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Hospital Mortality; Humans; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline | 2014 |
Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Indoles; Microbial Sensitivity Tests; Pyrans; Uridine Diphosphate N-Acetylmuramic Acid | 2014 |
Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2014 |
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cohort Studies; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Incidence; Male; Middle Aged; Spain | 2014 |
Tracking colistin-treated patients to monitor the incidence and outcome of carbapenem-resistant Gram-negative infections.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Colistin; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; United States | 2015 |
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Health Surveys; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories, Hospital; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sentinel Surveillance | 2014 |
Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Doripenem; Microbial Sensitivity Tests; Models, Statistical | 2015 |
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin | 2014 |
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Retrospective Studies | 2015 |
A nightmare for haematology clinics: extensively drug-resistant (XDR) Acinetobacter baumannnii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hematology; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Sulbactam; Survival Rate; Treatment Outcome; Turkey | 2014 |
Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Minocycline; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Tigecycline | 2016 |
The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Gene Expression Profiling; Models, Theoretical; Sequence Analysis, RNA; Time Factors | 2015 |
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2015 |
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male | 2015 |
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surveys and Questionnaires; Taiwan | 2016 |
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Pseudomonas aeruginosa; Time Factors | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Topics: Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Organ Dysfunction Scores; Prospective Studies; Taiwan; Tigecycline | 2015 |
In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time?
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome | 2015 |
Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2015 |
Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Organ Dysfunction Scores; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Thailand | 2015 |
High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Hip; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins | 2015 |
Emergence of Carbapenem-Resistant Klebsiella pneumoniae: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Female; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Fluoroquinolones; Gene Expression; Hospitals; Humans; Incidence; Italy; Klebsiella Infections; Klebsiella pneumoniae; Membrane Proteins; Multilocus Sequence Typing; Mutation; Plasmids | 2015 |
Antimicrobial resistance of Pseudomonas spp. isolated from wastewater and wastewater-impacted marine coastal zone.
Topics: Anti-Infective Agents; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Microbial; Environmental Monitoring; Fluoroquinolones; Microbial Sensitivity Tests; Oceans and Seas; Phylogeny; Poland; Pseudomonas; Seawater; Wastewater; Water Purification | 2015 |
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Colistin; Drug Synergism; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Vietnam | 2015 |
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multiplex Polymerase Chain Reaction; Tigecycline; Turkey | 2015 |
First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Tigecycline | 2015 |
"Excess Mortality" and Colistin-Tigecycline for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Colectomy; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Valganciclovir | 2015 |
In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Tigecycline; Young Adult | 2015 |
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin; Young Adult | 2015 |
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Mortality and Extensively Drug Resistance: Drugs or Methods? That Is the Question!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter koseri; Colistin; Conjugation, Genetic; Croatia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Gene Transfer, Horizontal; Humans; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Plasmids; Sequence Analysis, DNA; Tigecycline | 2016 |
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Administration Schedule; Drug Dosage Calculations; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Colistin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Leukemia; Male; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA | 2015 |
Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactams; Camellia sinensis; Carbapenems; Colistin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Flavonoids; Free Radical Scavengers; Meropenem; Microbial Sensitivity Tests; Minocycline; Phytochemicals; Plant Extracts; Plant Leaves; Thienamycins; Tigecycline | 2016 |
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing | 2015 |
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline | 2016 |
Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Humans; India; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Tertiary Care Centers; Treatment Outcome; Young Adult | 2015 |
Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Humans; India; Male; Microbial Sensitivity Tests; Plasmids; Providencia; Pseudomonas aeruginosa | 2016 |
Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.
Topics: Carbapenems; Colistin; Colorado; Drug Resistance, Multiple; Enterobacter cloacae; Gram-Negative Bacteria; Microbial Sensitivity Tests | 2016 |
Colistin and Tigecycline Resistance in Carbapenem-Resistant Enterobacteriaceae: Checkmate to Our Last Line Of Defense.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2016 |
Detection of the mcr-1 Colistin Resistance Gene in Carbapenem-Resistant Enterobacteriaceae from Different Hospitals in China.
Topics: Anti-Bacterial Agents; Carbapenems; China; Chromosomes, Bacterial; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Hospitals; Microbial Sensitivity Tests | 2016 |
Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance.
Topics: Acinetobacter baumannii; Carbapenems; Colistin; Klebsiella pneumoniae; Reproducibility of Results | 2016 |
mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Estonia; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; South Africa | 2016 |
Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2016 |
More Furious Than Ever: Escherichia coli-Acquired Co-resistance Toward Colistin and Carbapenems.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids | 2016 |
In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Prospective Studies; Republic of Korea; Rifampin; Tertiary Care Centers | 2016 |
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacteriuria; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam; Trachea; Wound Infection | 2016 |
Transmissible colistin resistance encoded by mcr-1 detected in clinical Enterobacteriaceae isolates in Singapore.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Plasmids; Singapore; Urine | 2016 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Taiwan; Thienamycins | 2016 |
Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Plasmids; Sequence Analysis, DNA; Sequence Homology; Travel; United States; Urinary Tract Infections; Urine | 2016 |
blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; India; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Molecular Typing | 2016 |
Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline; Tobramycin | 2016 |
Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asian People; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Thienamycins | 2016 |
Investigation of Extensively Drug-Resistant blaOXA-23-Producing Acinetobacter baumannii Spread in a Greek Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Greece; Hospitals; Humans; Intensive Care Units; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Mutation; Retrospective Studies; Survival Analysis; Tigecycline; Transcription Factors | 2017 |
Open Conversion after Aortic Endograft Infection Caused by Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortography; Bacterial Proteins; beta-Lactamases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Carbapenems; Colistin; Computed Tomography Angiography; Device Removal; Drug Resistance, Bacterial; Endovascular Procedures; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Treatment Outcome | 2016 |
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Health Status Indicators; Humans; Male; Mortality; Prospective Studies | 2016 |
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Polymerase Chain Reaction; Prospective Studies; Renal Dialysis; Risk Factors; Shock, Septic; Urinary Tract Infections | 2016 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline | 2017 |
A Silent Epidemic of Colistin- and Carbapenem-Resistant Enterobacteriaceae at a Turkish University Hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans | 2017 |
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Comorbidity; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Proportional Hazards Models | 2017 |
Various Sequence Types of Escherichia coli Isolates Coharboring
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Transfer, Horizontal; Genetic Fitness; Genotype; Plasmids; Swine; Swine Diseases | 2017 |
Genome Analysis of the Carbapenem- and Colistin-Resistant Escherichia coli Isolate NRZ14408 Reveals Horizontal Gene Transfer Pathways towards Panresistance and Enhanced Virulence.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Plasmids; Virulence; Whole Genome Sequencing | 2017 |
Colistin- and carbapenem-resistant Klebsiella oxytoca harboring bla
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood; Blood Culture; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Membrane Proteins; Mutagenesis, Insertional; Plasmids | 2017 |
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study.
Topics: Animals; Carbapenems; Case-Control Studies; China; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Healthy Volunteers; Humans; Molecular Epidemiology; Plasmids; Prevalence; Prospective Studies; Retrospective Studies; Risk Factors; Sex Factors | 2017 |
Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Gene Expression; Humans; Kuwait; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Oman; Phylogeny; Plasmids; Saudi Arabia; Tigecycline; United Arab Emirates | 2017 |
Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Patient Isolation; Population Surveillance; Predictive Value of Tests; Prospective Studies | 2017 |
Carriage of type II toxin-antitoxin systems by the growing group of IncX plasmids.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Conjugation, Genetic; Databases, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Phylogeny; Plasmids; Sequence Analysis, DNA; Toxin-Antitoxin Systems | 2017 |
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxin B; Thienamycins | 2017 |
Correct Definitions for Mobile Genetic Elements.
Topics: Carbapenems; Colistin; Escherichia coli; Interspersed Repetitive Sequences | 2017 |
Reply to Mc Gann.
Topics: Algorithms; Carbapenems; Colistin; Escherichia coli | 2017 |
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2017 |
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inpatients; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an IS
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Republic of Korea; United Arab Emirates | 2017 |
Molecular characterization of carbapenem- resistant Enterobacteriaceae yields increasing rates of NDM-1 carbapenemases and colistin resistance in an OXA-48- endemic area.
Topics: Adolescent; Adult; Aged; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Microbial; Endemic Diseases; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Turkey; Young Adult | 2017 |
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Chromosomal Integration of Plasmid DNA.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Membrane Proteins; Mutagenesis, Insertional; Plasmids | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Female; Genes, Bacterial; Humans; Lebanon; Male; Microbial Sensitivity Tests | 2017 |
Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Automation; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Tertiary Care Centers | 2017 |
Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Cutaneous; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Arginine; Bacteremia; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Ear; Humans; Mice; Proline; Skin; Survival Analysis | 2017 |
First report of an Escherichia coli strain from swine carrying an OXA-181 carbapenemase and the colistin resistance determinant MCR-1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Transfer, Horizontal; Italy; Multilocus Sequence Typing; Plasmids; Swine | 2017 |
Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Disease Susceptibility; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Minocycline; Risk Factors; Tigecycline | 2017 |
Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fenoterol; Gene Deletion; Humans; Interspersed Repetitive Sequences; Plasmids; Replication Origin; Sequence Analysis, DNA; Swine | 2017 |
Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Leukopenia; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Survival Analysis; Thrombocytopenia | 2017 |
Emergence of carbapenem-resistant Acinetobacter baumannii ST787 in clinical isolates from blood in a tertiary teaching hospital in Northern Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Taiwan; Tertiary Care Centers | 2017 |
Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2017 |
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Topics: Aged; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Propensity Score; Tertiary Care Centers; Tigecycline; Treatment Outcome | 2018 |
Letter to the Editor: Surveillance of mcr-1 and mcr-2 genes in Carbapenem-resistant Klebsiella pneumoniae strains from an Italian Hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Cohort Studies; Colistin; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Propensity Score; Survival Analysis; Tigecycline; Treatment Outcome | 2018 |
Reply to Macesic et al.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella pneumoniae; Prostatic Neoplasms | 2017 |
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Fluoroquinolones; Genome, Bacterial; Genotype; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Whole Genome Sequencing | 2017 |
Widespread distribution of
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Ecosystem; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Feces; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Sentinel Surveillance; Water Microbiology | 2017 |
Colistin Area Under the Time-Concentration in Children Treated With Intravenous Loading Dose and Maintenance Therapy.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Child; Child, Preschool; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Injections, Intravenous; Underage Drinking | 2018 |
[Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam | 2017 |
Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Middle Aged; Minocycline; Polymorphism, Single Nucleotide; Rifampin; Tigecycline; Transcription Factors | 2018 |
Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Microbial Sensitivity Tests; Plasmids | 2017 |
Acquisition of the mcr-1 gene by a high-risk clone of KPC-2-producing Klebsiella pneumoniae ST437/CC258, Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.
Topics: Bacterial Proteins; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Point Mutation; Vietnam | 2018 |
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Anti-Bacterial Agents; Blood-Brain Barrier; Carbapenems; Cerebral Ventriculitis; Colistin; Female; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Surgical Wound Infection | 2018 |
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2018 |
Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Vietnam; Whole Genome Sequencing | 2018 |
Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Female; Hospitals; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Young Adult | 2018 |
Antibiotic Resistance of Acinetobacter spp. Isolates from the River Danube: Susceptibility Stays High.
Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rivers | 2017 |
IncX3 Epidemic Plasmid Carrying
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Expression; Plasmids; Replicon; Swine | 2018 |
Clinical Validation of SensiTest Colistin, a Broth Microdilution-Based Method To Evaluate Colistin MICs.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Plasmids; Reproducibility of Results | 2018 |
Comparative Evaluation of Broth Microdilution with Polystyrene and Glass-Coated Plates, Agar Dilution, E-Test, Vitek, and Disk Diffusion for Susceptibility Testing of Colistin and Polymyxin B on Carbapenem-Resistant Clinical Isolates of Acinetobacter baum
Topics: Acinetobacter baumannii; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Polystyrenes; Reproducibility of Results | 2018 |
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand | 2018 |
Microbiological surveillance of plasmid mediated colistin resistance in human Enterobacteriaceae isolates in Romagna (Northern Italy): August 2016-July 2017.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Eggs; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Food Contamination; Food Microbiology; Foodborne Diseases; Humans; Italy; Meat; Plasmids; Risk Factors | 2018 |
Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria.
Topics: Carbapenems; Colistin; Gram-Negative Bacteria; Meropenem | 2018 |
Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B | 2018 |
Extensively drug-resistant Acinetobacter baumannii bacteraemia in a multidisciplinary intensive care unit during a 6-year period: Risk factors for fulminant sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis | 2018 |
Carbapenem-Resistant
Topics: Animals; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Enterobacteriaceae; Klebsiella Infections; Klebsiella pneumoniae; Mice; Polymyxins | 2018 |
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline | 2018 |
The global distribution and spread of the mobilized colistin resistance gene mcr-1.
Topics: Americas; Anti-Bacterial Agents; Asia; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Europe; Evolution, Molecular; Gene Expression; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Plasmids; Population Dynamics | 2018 |
Colistin versus colistin plus meropenem for severe infections.
Topics: Carbapenems; Colistin; Gram-Negative Bacteria; Meropenem | 2018 |
Colistin versus colistin plus meropenem for severe infections.
Topics: Carbapenems; Colistin; Gram-Negative Bacteria; Meropenem | 2018 |
Colistin versus colistin plus meropenem for severe infections Authors' reply.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Meropenem | 2018 |
First report of the isolation of bla
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests | 2018 |
Use of succinic & oxalic acid in reducing the dosage of colistin against New Delhi metallo-β-lactamase-1 bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Humans; Microbial Sensitivity Tests; Oxalic Acid; Succinic Acid | 2018 |
Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Taiwan; Tigecycline; Virulence | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Whole Genome Sequencing | 2018 |
Evaluation of the Rapid Polymyxin NP test for detection of colistin susceptibility in Enterobacteriaceae isolated from Thai patients.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Thailand | 2018 |
Screening and Characterization of Multidrug-Resistant Gram-Negative Bacteria from a Remote African Area, São Tomé and Príncipe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymyxins; RNA, Ribosomal, 16S; Sao Tome and Principe | 2018 |
A clinical isolate of Escherichia coli co-harbouring mcr-1 and blaNDM-5 in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Japan; Male; Molecular Typing; Plasmids | 2018 |
Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carbapenems; Caspofungin; Colistin; Diarrhea; Drug Resistance, Bacterial; Echinocandins; Feces; Gastrointestinal Tract; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Monocytic, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Minocycline; Tigecycline; Treatment Outcome | 2018 |
Carbapenem non-susceptibility of
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Germany; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Coidentification of
Topics: beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Microbial Sensitivity Tests; Plasmids; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Antibiotic exposure elicits the emergence of colistin- and carbapenem-resistant Escherichia coli coharboring MCR-1 and NDM-5 in a patient.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids | 2018 |
Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Colistin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Republic of Korea | 2018 |
Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Switzerland | 2018 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
Topics: Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Genomics; Hospitalization; Humans; Microbial Sensitivity Tests; Mutation; Phylogeny; Polymorphism, Single Nucleotide; Tertiary Care Centers; United States; Whole Genome Sequencing | 2018 |
Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; False Positive Reactions; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Sensitivity and Specificity; Tertiary Care Centers | 2018 |
Evaluation of the AusDiagnostics MT CRE EU assay for the detection of carbapenemase genes and transferable colistin resistance determinants mcr-1/-2 in MDR Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Retrospective Studies | 2018 |
Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: Algeria.
Topics: Algeria; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Emergence of a carbapenem-resistant and colistin-heteroresistant Enterobacter cloacae clinical isolate in Japan.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Diarrhea; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Feces; Female; Humans; Japan; Microbial Sensitivity Tests; Mutation | 2019 |
Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology | 2019 |
Characterization of a multidrug resistant Citrobacter amalonaticus clinical isolate harboring bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phylogeny | 2019 |
In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Lepidoptera; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Hospitals; Humans; India; Intensive Care Units; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Typing; Phenotype; Prevalence; Prospective Studies; Respiratory Tract Infections; Species Specificity; Virulence | 2019 |
Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Communicable Diseases; Cost-Benefit Analysis; Drug Utilization; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Saudi Arabia; Tertiary Care Centers; Vancomycin; Young Adult | 2018 |
The emergence of colistin-resistant Klebsiella pneumoniae strains from swine in Malaysia.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Genotyping Techniques; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Swine; Swine Diseases | 2019 |
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Survival Rate; Tigecycline; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Effect of rifampicin-colistin combination against XDR Acinetobacter baumannii harbouring bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Egypt; Hospitals, University; Humans; Microbial Sensitivity Tests; Rifampin | 2019 |
A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Genotype; Klebsiella pneumoniae; Microbial Sensitivity Tests; Virulence | 2019 |
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Vancomycin | 2019 |
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Tigecycline | 2019 |
In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Tetracyclines | 2019 |
Molecular Detection of Carbapenem Resistance in Acinetobacter Baumannii Isolated From Patients in Khorramabad City, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Iran; Microbial Sensitivity Tests; Sulbactam | 2020 |
Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Oman; Prevalence; Pseudomonas aeruginosa | 2019 |
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Cost-Benefit Analysis; Drug Combinations; Europe; Gram-Negative Bacteria; Humans; Imipenem; Length of Stay; National Health Programs; United States; Urinary Tract Infections | 2019 |
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
Topics: Argentina; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids | 2019 |
Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria.
Topics: Acinetobacter; Bacterial Infections; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; India; Microbial Sensitivity Tests; Molecular Epidemiology; Pseudomonas aeruginosa | 2019 |
Retrospective analysis of colistin-resistant bacteria in a tertiary care centre in India.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Dual Role of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Lepidoptera; Microbial Sensitivity Tests; Minocycline; Tigecycline; Virulence | 2019 |
Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Oxazines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Xanthenes | 2019 |
Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Microbial Sensitivity Tests | 2019 |
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tigecycline; Young Adult | 2019 |
Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chlorhexidine; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2019 |
Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Proteins; Microbial Sensitivity Tests; Transcription Factors; Whole Genome Sequencing | 2019 |
Genomic Insights into Two Colistin-Resistant
Topics: Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Genes, Bacterial; Genomics; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Virulence; Whole Genome Sequencing | 2020 |
Colistin, Hot Potato for the Therapy of Carbapenem-resistant
Topics: Acinetobacter baumannii; Bacteremia; Carbapenems; Colistin; Humans; Prognosis; Propensity Score; Solanum tuberosum | 2019 |
Emergence of mcr-1 conferred colistin resistance among bacterial isolates from urban sewage water in India.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; India; Microbial Sensitivity Tests; Plasmids; Sewage | 2019 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Colistin; Communicable Diseases; Drug Resistance, Bacterial; Feces; Genetic Variation; Genotype; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2019 |
Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests | 2020 |
The first report of colistin-carbapenem resistance in Klebsiella pneumoniae ST70 isolated from the pediatric unit in India.
Topics: Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Colistin; Drug Resistance, Multiple, Bacterial; Humans; India; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Mutation | 2020 |
Reply to Wilson et al.
Topics: Acinetobacter baumannii; Carbapenems; Colistin; Humans; Treatment Outcome | 2020 |
Acinetobacter Infections.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Colistin; Humans; Treatment Outcome | 2020 |
In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline | 2019 |
Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Iran | 2020 |
Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing | 2020 |
A Cluster of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Carrying blaNDM-1 and mcr-8.2.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Whole Genome Sequencing | 2020 |
Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors | 2019 |
Detection of mobile colistin resistance gene mcr-9 in carbapenem-resistant Klebsiella pneumoniae strains of human origin in Europe.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Europe; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2020 |
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2020 |
Prevalence of Colistin-Resistant, Carbapenem-Hydrolyzing Proteobacteria in Hospital Water Bodies and Out-Falls of West Bengal, India.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prevalence; Proteobacteria; Wastewater | 2020 |
Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Pakistan; Tertiary Care Centers; Tigecycline | 2019 |
Performance of Rapid Polymyxin™ NP and Rapid Polymyxin™ Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Europe; Humans; Israel; Microbial Sensitivity Tests; Polymyxins; Sheep | 2020 |
Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2020 |
Intestinal carriage of colistin resistant Enterobacteriaceae in hospitalized patients from an Indian center.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Carrier State; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Feces; Female; Hospitalization; Humans; India; Intestines; Klebsiella; Male; Microbial Sensitivity Tests; Mutation | 2020 |
In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Young Adult | 2020 |
Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Humans; Microbial Sensitivity Tests; Travel; United States | 2020 |
A Novel Deletion Mutation in
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Sequence Deletion | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes' by Nutman et al.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2020 |
Pulsed electric field application reduces carbapenem- and colistin-resistant microbiota and bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Microbiota; Ohio; Wastewater | 2020 |
The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests | 2020 |
In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
Topics: beta-Lactamases; Carbapenems; Colistin; Drug Synergism; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Klebsiella pneumoniae; Microscopy, Electron, Scanning; Phylogeny; Whole Genome Sequencing | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant gram-negative infections: in vitro synergism is not associated with better clinical outcomes'-Author's reply.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2020 |
Genomic characterization of XDR Klebsiella pneumoniae ST147 co-resistant to carbapenem and colistin - The first report in India.
Topics: Carbapenems; Colistin; Genomics; Humans; India; Klebsiella Infections; Klebsiella pneumoniae | 2020 |
The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Male; Meropenem; Middle Aged; Retrospective Studies; Thailand | 2020 |
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Sulbactam | 2020 |
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Cell Membrane Permeability; Colistin; Disease Models, Animal; Drug Discovery; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Helminth Proteins; Humans; Male; Mice; Microbial Sensitivity Tests; Peritonitis; Pneumonia; Urinary Tract Infections | 2020 |
Colistin monotherapy versus colistin-based combination therapy for treatment of bacteremia in burn patients due to carbapenem-resistant gram negative bacteria.
Topics: Adult; Aged; Bacteremia; Burns; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2020 |
Imipenem-relebactam for Treatment of Carbapenem-resistant Gram-negative Bacteria: Where Do We Stand on In Vitro Susceptibility Testing?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Carbapenems; Colistin; Double-Blind Method; Gram-Negative Bacteria; Humans; Imipenem | 2021 |
Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Plasmids; Republic of Korea; Whole Genome Sequencing | 2020 |
Implementation and evaluation of methods for the optimal detection of carbapenem-resistant and colistin-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from stools.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity | 2020 |
Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Coinfection; Colistin; COVID-19; Drug Resistance, Bacterial; Humans; Models, Theoretical; Pneumonia, Ventilator-Associated | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes' by Nutman et al.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2021 |
PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Microbial Sensitivity Tests; Mutagenesis, Insertional; Transcription Factors | 2020 |
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin.
Topics: Animals; Anti-Bacterial Agents; Auranofin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests | 2020 |
Komodo-dragon cathelicidin-inspired peptides are antibacterial against carbapenem-resistant
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cathelicidins; Colistin; Klebsiella Infections; Klebsiella pneumoniae; Lizards; Microbial Sensitivity Tests; Moths | 2020 |
Carbapenem and colistin resistance in children with Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Colistin; Enterobacteriaceae Infections; Humans; Infant, Newborn; Retrospective Studies | 2020 |
Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Capsules; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Virulence; Virulence Factors | 2020 |
High prevalence and persistence of carbapenem and colistin resistance in livestock farm environments in China.
Topics: Animals; Anti-Bacterial Agents; Attention; Carbapenems; Chickens; China; Colistin; Drug Resistance, Bacterial; Farms; Livestock; Prevalence; Swine | 2021 |
Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Turkey | 2020 |
Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Escherichia coli; Female; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Kuwait; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Prevalence; Rectum; Young Adult | 2020 |
Insertion sequences disrupting mgrB in carbapenem-resistant Klebsiella pneumoniae strains in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines | 2021 |
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Escherichia coli; Escherichia coli Infections; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2021 |
In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2021 |
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2021 |
Characterization of DtrJ as an IncC plasmid conjugative DNA transfer component.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Plasmids; Transferases (Other Substituted Phosphate Groups) | 2021 |
Associated factors of Acinetobacter baumannii complex in hospitalized patients: A case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Risk Factors; Young Adult | 2021 |
Performance of polymyxin B agar-based tests among carbapenem-resistant Enterobacterales.
Topics: Agar; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Polymyxin B; Polymyxins | 2021 |
Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pakistan; Prospective Studies; Treatment Outcome | 2021 |
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Thailand | 2021 |
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Greece; Humans; Israel; Italy; Logistic Models; Male; Meropenem; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Tertiary Care Centers | 2021 |
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 'superplasmids' in clinical carbapenem-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids | 2021 |
Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Sepsis | 2021 |
Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2021 |
Identification of a carbapenem-resistant Enterobacter kobei clinical strain co-harbouring mcr-4.3 and mcr-9 in Republic of Korea.
Topics: Carbapenems; Colistin; Enterobacter; Republic of Korea | 2021 |
Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacter cloacae; Genes, Bacterial; Plasmids | 2021 |
Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia-Pacific region, 2015-2018.
Topics: Anti-Bacterial Agents; Asia, Eastern; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Role of Coptis chinensis in antibiotic susceptibility of carbapenem-resistant Klebsiella pneumoniae.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Coptis chinensis; Klebsiella pneumoniae | 2022 |
Carbapenem and colistin-resistant bacteria in North Lebanon: Coexistence of mcr-1 and NDM-4 genes in Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Genotype; Gram-Negative Bacteria; Humans; Lebanon; Multilocus Sequence Typing; Phenotype; Real-Time Polymerase Chain Reaction | 2021 |
Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Chickens; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids; Poultry Diseases | 2021 |
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Colombia; Cost-Benefit Analysis; Drug Combinations; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Colistin resistance and plasmid-mediated
Topics: Animals; Anti-Bacterial Agents; Cambodia; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Laos; Plasmids; Pork Meat; Salmonella; Sus scrofa; Thailand | 2021 |
Complete Genetic Analysis of Plasmids Carried by Two Nonclonal
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Meat; Microbial Sensitivity Tests; Plasmids; Whole Genome Sequencing | 2021 |
In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Tigecycline | 2021 |
Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Clone Cells; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids | 2021 |
Carbapenem and Colistin Resistant Klebsiella Pneumoniae ST14 and ST2096 Dominated in Two Hospitals in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Turkey | 2021 |
Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Young Adult | 2022 |
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Genome, Bacterial; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Whole Genome Sequencing | 2021 |
Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cancer Care Facilities; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Hospitals, Pediatric; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Whole Genome Sequencing | 2021 |
The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan.
Topics: beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli Proteins; Genetic Variation; Genotype; Humans; Japan; Population Surveillance | 2022 |
Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Humans | 2023 |
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Male; Middle Aged; Prevalence; Pseudomonas aeruginosa | 2022 |
In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Tazobactam | 2022 |
Prevalence, risk factors and emergence of extended-spectrum β-lactamase producing-, carbapenem- and colistin-resistant Enterobacterales isolated from wild boar (Sus scrofa) in Tunisia.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Prevalence; Risk Factors; Sus scrofa; Swine; Tunisia | 2022 |
High-level carbapenem tolerance requires antibiotic-induced outer membrane modifications.
Topics: Anti-Bacterial Agents; Antimicrobial Peptides; Bacterial Proteins; Carbapenems; Cell Membrane; Colistin; Drug Tolerance; Enterobacter cloacae; Gene Expression Regulation; Histidine Kinase; Humans; Lipid A; Lipopolysaccharides; Membrane Proteins; Microbial Sensitivity Tests | 2022 |
Epidemiology and genotypic characteristics of carbapenem resistant Enterobacterales in Henan, China: a multicentre study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Colistin; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Cross Infection; Drug Resistance, Microbial; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteriophages; Biofilms; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Phage Therapy; Podoviridae | 2022 |
Phenotypic Changes Associated With
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2022 |
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales.
Topics: Agar; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Fosfomycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Tigecycline | 2022 |
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2022 |
The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Humans; Pneumonia, Bacterial; Retrospective Studies | 2022 |
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines | 2022 |
A fatal outbreak of neonatal sepsis caused by mcr-10-carrying Enterobacter kobei in a tertiary care hospital in Nepal.
Topics: Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Nepal; Tertiary Care Centers | 2022 |
[In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Humans; Klebsiella pneumoniae; Meropenem | 2022 |
[Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Cross Infection; Gram-Negative Bacteria; Healthcare-Associated Pneumonia; Humans; Retrospective Studies | 2022 |
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Combinations; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Rifampin; Tazobactam; Tigecycline | 2022 |
Therapeutic drug monitoring of colistin in plasma and cerebrospinal fluid in meningoventriculitis caused by a carbapenem-resistant Enterobacter cloacae.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Monitoring; Enterobacter cloacae | 2022 |
Higher Rate of Extreme Drug-resistant Klebsiella pneumoniae Infections among Cardiac Patients.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nepal | 2022 |
Investigation of the Relationship between Colistin Resistance and Capsule Serotypes in Carbapenem Resistant Klebsiella pneumoniae Strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serogroup | 2022 |
Co-transfer of mcr-8 with bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids; Tigecycline | 2022 |
Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; DNA Transposable Elements; Humans; Klebsiella Infections; Klebsiella pneumoniae; Polymyxin B; Polymyxins | 2022 |
Clinical and Genomic Epidemiology of
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Genomics; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2022 |
[Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina].
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Child; Colistin; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2022 |
Emergence and Evolution of Unique Plasmids Harboring
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Microbial Sensitivity Tests; Plasmids; Providencia | 2022 |
Genomic Epidemiology of Carbapenemase-Producing and Colistin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Enterobacteriaceae; Ethiopia; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2022 |
Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Jordan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Demonstration of the efficacy of curcumin on carbapenem-resistant Pseudomonas aeruginosa with Galleria mellonella larvae model.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Curcumin; Drug Resistance, Multiple, Bacterial; Larva; Microbial Sensitivity Tests; Moths; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Edetic Acid; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Prevalence | 2022 |
Carriage of the mcr-9 and mcr-10 genes in clinical strains of the Enterobacter cloacae complex in China: a prevalence and molecular epidemiology study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacter cloacae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Prevalence | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Spatiotemporal Investigation of Antibiotic Resistance in the Urban Water Cycle Influenced by Environmental and Anthropogenic Activity.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthropogenic Effects; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Gentamicins; Sewage; Sulfamethoxazole; Wastewater; Water Cycle | 2022 |
Phage-Plasmids Spread Antibiotic Resistance Genes through Infection and Lysogenic Conversion.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; DNA Transposable Elements; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Plasmids; Plastics | 2022 |
Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Colistin; Disinfectants; Drug Resistance, Multiple, Bacterial; Humans; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests | 2022 |
Trends of Bloodstream Infections in a University Hospital During 12 Years.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Coagulase; Colistin; Escherichia coli; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2022 |
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Tigecycline | 2022 |
Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colistin; Female; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; South Africa; Tertiary Care Centers; Young Adult | 2022 |
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin | 2022 |
Whole-cell vaccine candidates induce a protective response against virulent
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Mice; Sulbactam | 2022 |
Molecular Screening of Clinical Multidrug-Resistant Gram-Negative Bacteria Shows Endemicity of Carbapenemases, Coexistence of Multiple Carbapenemases, and Rarity of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; South Africa | 2022 |
How to Manage Pseudomonas aeruginosa Infections.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Identification of three Enterobacter asburiae isolates co-resistant to carbapenem and colistin in a hospital in Gangwon Province, South Korea.
Topics: Carbapenems; Colistin; Enterobacter; Hospitals | 2022 |
Plasmidome in mcr-1 harboring carbapenem-resistant enterobacterales isolates from human in Thailand.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Thailand | 2022 |
Genome Assessment of Carbapenem- and Colistin-Resistant
Topics: Animals; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals; Microbial Sensitivity Tests; Plasmids | 2022 |
Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Tigecycline | 2022 |
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Azithromycin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moths | 2023 |
Increasing Frequency of New Delhi Metallo-beta-Lactamase and Klebsiella pneumoniae Carbapenemase Resistant Genes in a Set of Population of Karachi.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Female; Fosfomycin; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tigecycline | 2023 |
The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Susceptibility; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Prevalence; Renal Dialysis; Retrospective Studies | 2023 |
Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Leadership; Meropenem; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2023 |
[Relationship of Hypervirulent Capsular Genotypes of Klebsiella pneumoniae with Antibiotic Susceptibility and Beta-Lactamase Genes].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clavulanic Acid; Colistin; Drug Resistance, Bacterial; Genotype; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin; Tazobactam | 2023 |
Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2023 |
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 pat
Topics: Anti-Bacterial Agents; Bacteriophages; Carbapenems; Colistin; COVID-19; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Ventilators, Mechanical | 2023 |
Whole-genome sequence analysis of clinically isolated carbapenem resistant Escherichia coli from Iran.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Escherichia coli; Escherichia coli Proteins; Imipenem; Iran; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Tigecycline | 2023 |
Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Europe; Humans | 2023 |
Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem-resistant Acinetobacter baumannii strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Imipenem; Mice; Microbial Sensitivity Tests; Sulbactam; Tigecycline | 2023 |
Carbapenem and Colistin Resistance, Integrons and Plasmid Replicon Types in Multi-Drug Resistant Klebsiella Strains Isolated in Turkey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Turkey | 2023 |
High prevalence of Escherichia coli co-harboring conjugative plasmids with colistin- and carbapenem resistance genes in a wastewater treatment plant in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence | 2023 |
Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Pairing Colicins B and E5 with Bdellovibrio bacteriovorus To Eradicate Carbapenem- and Colistin-Resistant Strains of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacteria; Bdellovibrio bacteriovorus; Carbapenems; Colicins; Colistin; Escherichia coli | 2023 |
Co-occurrence of blaNDM-1, rmtC, and mcr-9 in multidrug-resistant Enterobacter kobei strain isolated from an infant with urinary tract infection.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Escherichia coli Proteins; Humans; Infant; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Urinary Tract Infections | 2023 |
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Colistin; COVID-19; Fosfomycin; Humans; Pneumonia, Ventilator-Associated | 2023 |
The clinical features and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii infections at a tertiary hospital in Vietnam.
Topics: Acinetobacter baumannii; Carbapenems; Colistin; Genomics; Humans; Interleukin-1 Receptor-Like 1 Protein; Microbial Sensitivity Tests; Phylogeny; Tertiary Care Centers; Vietnam | 2023 |
A survey of Salmonella, Escherichia coli, and antimicrobial resistance in frozen, part-cooked, breaded, or battered chicken products on retail sale in the UK.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; United Kingdom | 2023 |
Epidemiology, Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacteria from a Libyan Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Gram-Negative Bacteria; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
Genomic Epidemiology and Characterization of Carbapenem-Resistant Klebsiella pneumoniae in ICU Inpatients in Henan Province, China: a Multicenter Cross-Sectional Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross-Sectional Studies; Genomics; Humans; Inpatients; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prevalence | 2023 |
Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxin B; Polymyxins; Retrospective Studies | 2023 |
Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipid A; Microbial Sensitivity Tests; Prevalence | 2023 |
Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Humans; Propensity Score; Retrospective Studies | 2023 |
Genomic characterisation of a bla
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Genomics; Humans | 2023 |
Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chile; Colistin; COVID-19; Hospitals; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pandemics; Phylogeny | 2023 |
Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Adult; Anti-Bacterial Agents; Bangladesh; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Microbial; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Prevalence; Staphylococcal Infections | 2023 |
Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
The Presence of Virulent and Multidrug-Resistant Clones of Carbapenem-Resistant Klebsiella pneumoniae in Southeastern Brazil.
Topics: Anti-Bacterial Agents; Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing | 2023 |
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia | 2023 |
Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disulfiram; Drug Combinations; Gram-Negative Bacteria; Meropenem | 2023 |
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Klebsiella pneumoniae; Myanmar; RNA, Ribosomal, 16S | 2023 |
The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Fosfomycin; Interleukin-6; Mesenchymal Stem Cells; Mice; Microbial Sensitivity Tests; Sepsis | 2023 |
Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae.
Topics: Animals; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Larva | 2023 |
Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Colistin; Gram-Negative Bacteria; Humans; Retrospective Studies | 2023 |
Evaluating molecular epidemiology of carbapenem non-susceptible Klebsiella pneumoniae isolates with MLST, MALDI-TOF MS, PFGE.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Investigation of carbapenem-resistant Enterobacterales isolates at a tertiary laboratory in Pretoria, South Africa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; South Africa | 2023 |
Molecular epidemiological investigation of carbapenem resistant Klebsiella pneumoniae isolated from intensive care unit patients of six geographical regions of Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Turkey | 2023 |
Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25).
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Interleukin-1 Receptor-Like 1 Protein; Microbial Sensitivity Tests; Phenotype; RNA, Ribosomal, 16S | 2023 |
Colistin-induced structural and biochemical changes in carbapenem-resistant Acinetobacter baumannii isolated from the hospital environment.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests | 2023 |